<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Physiol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Physiol. (Lond.)</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1469-7793</journal-id>
<journal-id journal-id-type="publisher-id">TJP</journal-id>
<journal-id journal-id-type="hwp">jphysiol</journal-id>
<journal-title-group>
<journal-title>The Journal of Physiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-3751</issn>
<issn pub-type="epub">1469-7793</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26821241</article-id>
<article-id pub-id-type="pmc">4983618</article-id>
<article-id pub-id-type="doi">10.1113/JP271195</article-id>
<article-id pub-id-type="publisher-id">TJP7081</article-id>
<article-categories>
<subj-group subj-group-type="article-subject-classification">
<subject>Neurological Conditions, Disorders and Treatments</subject>
</subj-group>
<subj-group subj-group-type="article-subject-classification">
<subject>Cellular and Molecular Neuroscience</subject>
</subj-group>
<subj-group subj-group-type="overline">
<subject>Symposium Review</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Symposium reviews</subject>
<subj-group subj-group-type="heading">
<subject>Editor's Choice</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Cerebellar ataxias: β‐III spectrin's interactions suggest common pathogenic pathways</article-title>
<alt-title alt-title-type="left-running-head">E. Perkins and others</alt-title>
<alt-title alt-title-type="right-running-head">Cerebellar ataxias</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="tjp7081-cr-0001">
<name>
<surname>Perkins</surname>
<given-names>Emma</given-names>
</name>
<xref ref-type="aff" rid="tjp7081-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="bio" rid="d36e59">*</xref>
</contrib>
<contrib contrib-type="author" id="tjp7081-cr-0002">
<name>
<surname>Suminaite</surname>
<given-names>Daumante</given-names>
</name>
<xref ref-type="aff" rid="tjp7081-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="bio" rid="d36e77">*</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="tjp7081-cr-0003">
<name>
<surname>Jackson</surname>
<given-names>Mandy</given-names>
</name>
<xref ref-type="aff" rid="tjp7081-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="bio" rid="d36e94">*</xref>
</contrib>
</contrib-group>
<aff id="tjp7081-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Centre for Integrative Physiology</named-content>
<institution>University of Edinburgh</institution>
<named-content content-type="street">Hugh Robson Building, George Square</named-content>
<named-content content-type="city">Edinburgh</named-content>
<named-content content-type="post-code">EH8 9XD</named-content>
<country country="GB">UK</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Corresponding author</bold> M. Jackson: Centre for Integrative Physiology, University of Edinburgh, Hugh Robson Building, George Square, Edinburgh EH8 9XD, UK. Email: <email>mandy.jackson@ed.ac.uk</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>24</day>
<month>4</month>
<year>2016</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>594</volume>
<issue>16</issue>
<issue-id pub-id-type="doi">10.1113/tjp.2016.594.issue-16</issue-id>
<fpage>4661</fpage>
<lpage>4676</lpage>
<history>
<date date-type="received">
<day>26</day>
<month>6</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>12</month>
<year>2015</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Journal compilation &#x000a9; 2016 The Physiological Society <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2016 The Authors. The Journal of Physiology published by John Wiley &amp; Sons Ltd on behalf of The Physiological Society</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:TJP-594-4661.pdf" xlink:type="simple"></self-uri>
<abstract>
<title>Abstract</title>
<p>Spinocerebellar ataxias (SCAs) are a genetically heterogeneous group of disorders all characterised by postural abnormalities, motor deficits and cerebellar degeneration. Animal and <italic>in vitro</italic> models have revealed β‐III spectrin, a cytoskeletal protein present throughout the soma and dendritic tree of cerebellar Purkinje cells, to be required for the maintenance of dendritic architecture and for the trafficking and/or stabilisation of several membrane proteins: ankyrin‐R, cell adhesion molecules, metabotropic glutamate receptor‐1 (mGluR1), voltage‐gated sodium channels (Na<sub>v</sub>) and glutamate transporters. This scaffold of interactions connects β‐III spectrin to a wide variety of proteins implicated in the pathology of many SCAs. Heterozygous mutations in the gene encoding β‐III spectrin (<italic>SPTBN2</italic>) underlie SCA type‐5 whereas homozygous mutations cause spectrin associated autosomal recessive ataxia type‐1 (SPARCA1), an infantile form of ataxia with cognitive impairment. Loss‐of β‐III spectrin function appears to underpin cerebellar dysfunction and degeneration in both diseases resulting in thinner dendrites, excessive dendritic protrusion with loss of planarity, reduced resurgent sodium currents and abnormal glutamatergic neurotransmission. The initial physiological consequences are a decrease in spontaneous activity and excessive excitation, likely to be offsetting each other, but eventually hyperexcitability gives rise to dark cell degeneration and reduced cerebellar output. Similar molecular mechanisms have been implicated for SCA1, 2, 3, 7, 13, 14, 19, 22, 27 and 28, highlighting alterations to intrinsic Purkinje cell activity, dendritic architecture and glutamatergic transmission as possible common mechanisms downstream of various loss‐of‐function primary genetic defects. A key question for future research is whether similar mechanisms underlie progressive cerebellar decline in normal ageing.
<boxed-text content-type="graphic" orientation="portrait" position="anchor"><graphic id="nlm-graphic-3" orientation="portrait" position="anchor" xlink:href="TJP-594-4661-g008.jpg"></graphic></boxed-text>
</p>
</abstract>
<counts>
<page-count count="16"></page-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>tjp7081</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>15 August 2016</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.4 mode:remove_FC converted:16.09.2016</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group>
<fn id="tjp6834-note-0001">
<p>This review was presented at the symposium “Mechanisms of cerebellar ataxias and neurodegeneration”, which took place at Ageing and Degeneration: A Physiological Perspective in Edinburgh, UK, 10–11 April 2015.</p>
</fn>
<fn id="tjp6834-note-0002">
<p>This is an Editor's Choice article from the 15 August 2016 issue.</p>
</fn>
</fn-group>
</notes>
</front>
<body>
<sec disp-level="2" id="tjp7081-sec-0020">
<title>Introduction</title>
<p>The cerebellum is essential for maintaining postural control and coordination of voluntary muscle movement (Manto, <xref ref-type="ref" rid="tjp7081-bib-0069">2008</xref>). Purkinje cells, the principal neurons and sole output of the cerebellar cortex, exhibit autonomous high‐frequency repetitive firing in addition to receiving input from inhibitory interneurons and two excitatory fibres, climbing and parallel fibres. Purkinje cells integrate the information and transmit timing signals essential for motor coordination in the form of inhibitory inputs to the deep cerebellar nuclei (DCN). The DCN, in turn, communicate with various parts of the nervous system controlling movement. Alterations to Purkinje cell and consequently DCN activity (Shakkottai <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0097">2004</xref>) are therefore sufficient to induce ataxia, a phenotype characterised by gait disturbances, postural instability and motor incoordination.</p>
<p>Autosomal dominant spinocerebellar ataxias (SCAs), a heterogeneous group of inherited neurodegenerative disorders, are a major cause of cerebellar ataxia. Their prevalence in several populations can be as high as 5–6 in 100,000 (Ruano <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0091">2014</xref>), similar to that of Huntington's and motor neuron disease. All SCAs can be characterised by postural abnormalities, progressive motor incoordination and cerebellar degeneration, but a number of subtypes can also be associated with additional neurological features such as cognitive impairment. To date 40 different genomic loci, numbered in order of discovery, have been associated with SCAs and the genes involved, along with the responsible mutations, have been identified for 26 SCA subtypes.</p>
<p>The first genetic defects to be identified as associating with SCA1, 2, 3, 6, 7 and 17 were coding for CAG repeat expansions, leading to proteins with abnormally long poly‐glutamine (polyQ) tracts (Orr <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0077">1993</xref>; Kawaguchi <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0054">1994</xref>; Imbert <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0045">1996</xref>; Pulst <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0086">1996</xref>; Sanpei <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0092">1996</xref>; David <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0021">1997</xref>; Zhuchenko <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0115">1997</xref>; Nakamura <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0075">2001</xref>). Together they account for more than half of all SCA cases, with SCA3 being the most common (Ruano <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0091">2014</xref>). Subsequently, non‐coding CAG repeats (Holmes <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0038">1999</xref>; Koob <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0059">1999</xref>), non‐CAG repeat expansions (Matsuura <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0071">2000</xref>; Sato <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0093">2009</xref>; Kobayashi <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0056">2011</xref>) and, more recently, conventional mutations have been found to underlie different SCA subtypes (Table <xref ref-type="table-wrap" rid="tjp7081-tbl-0001">1</xref>). This latter category is ever expanding, due to the advent of whole‐exome sequencing, and although conventional mutations are often associated with rarer forms of SCA, they have provided substantial insight into the physiological defects underlying ataxia.</p>
<table-wrap id="tjp7081-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Conventional mutations and molecular mechanisms underlying spinocerebellar ataxias</p>
</caption>
<table frame="hsides" rules="groups">
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<thead>
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1">SCA subtype</th>
<th align="center" colspan="1" rowspan="1">Gene</th>
<th align="center" colspan="1" rowspan="1">Protein</th>
<th align="center" colspan="1" rowspan="1">Normal function</th>
<th align="center" colspan="1" rowspan="1">Disease mechanism</th>
<th align="center" colspan="1" rowspan="1">DNA mutations</th>
<th align="center" colspan="1" rowspan="1">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">SCA5/SPARCA1</td>
<td align="left" colspan="1" rowspan="1">SPTBN2</td>
<td align="left" colspan="1" rowspan="1">β‐III spectrin</td>
<td align="left" colspan="1" rowspan="1">Membrane support, protein trafficking<sub>,</sub> stabilisation</td>
<td align="left" colspan="1" rowspan="1">Loss‐of‐function, DN</td>
<td align="left" colspan="1" rowspan="1">ID, MM, FM</td>
<td align="left" colspan="1" rowspan="1">Ikeda <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0044">2006</xref>; Lise <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0063">2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCA11</td>
<td align="left" colspan="1" rowspan="1">TTBK2</td>
<td align="left" colspan="1" rowspan="1">Tau tubulin kinase 2</td>
<td align="left" colspan="1" rowspan="1">Protein phosphorylation, ciliogenesis</td>
<td align="left" colspan="1" rowspan="1">Loss‐of‐function, DN</td>
<td align="left" colspan="1" rowspan="1">FM</td>
<td align="left" colspan="1" rowspan="1">Houlden <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0039">2007</xref>; Goetz <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0030">2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCA13</td>
<td align="left" colspan="1" rowspan="1">KCNC3</td>
<td align="left" colspan="1" rowspan="1">K<sub>v</sub>3.3</td>
<td align="left" colspan="1" rowspan="1">Neuronal excitability, K<sup>+</sup> homeostasis</td>
<td align="left" colspan="1" rowspan="1">Loss‐of‐function, DN</td>
<td align="left" colspan="1" rowspan="1">MM</td>
<td align="left" colspan="1" rowspan="1">Waters <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0111">2006</xref>; Irie <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0046">2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCA14</td>
<td align="left" colspan="1" rowspan="1">PRKCG</td>
<td align="left" colspan="1" rowspan="1">Protein kinase C (PKC)</td>
<td align="left" colspan="1" rowspan="1">Protein phosphorylation</td>
<td align="left" colspan="1" rowspan="1">Unknown</td>
<td align="left" colspan="1" rowspan="1">MM, D</td>
<td align="left" colspan="1" rowspan="1">Chen <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0010">2003</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCA15/16/29</td>
<td align="left" colspan="1" rowspan="1">ITPR1</td>
<td align="left" colspan="1" rowspan="1">Inositol 1,4,5‐trisphosphate receptor type 1</td>
<td align="left" colspan="1" rowspan="1">Calcium homeostasis</td>
<td align="left" colspan="1" rowspan="1">Loss‐of‐function</td>
<td align="left" colspan="1" rowspan="1">MM, D</td>
<td align="left" colspan="1" rowspan="1">van de Leemput <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0105">2007</xref>; Iwaki <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0047">2008</xref>; Huang <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0041">2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCA19/22</td>
<td align="left" colspan="1" rowspan="1">KCND3</td>
<td align="left" colspan="1" rowspan="1">K<sub>v</sub>4.3</td>
<td align="left" colspan="1" rowspan="1">Neuronal excitability, K<sup>+</sup> homeostasis</td>
<td align="left" colspan="1" rowspan="1">Loss‐of‐function, DN</td>
<td align="left" colspan="1" rowspan="1">ID, MM</td>
<td align="left" colspan="1" rowspan="1">Duarri et al. <xref ref-type="ref" rid="tjp7081-bib-0026">2012</xref>; Lee <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0061">2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCA23</td>
<td align="left" colspan="1" rowspan="1">PDYN</td>
<td align="left" colspan="1" rowspan="1">Prodynorphin</td>
<td align="left" colspan="1" rowspan="1">Opioid signalling</td>
<td align="left" colspan="1" rowspan="1">Unknown</td>
<td align="left" colspan="1" rowspan="1">MM, D</td>
<td align="left" colspan="1" rowspan="1">Bakalkin <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0004">2010</xref>; Jezierska <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0051">2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCA26</td>
<td align="left" colspan="1" rowspan="1">EEF2</td>
<td align="left" colspan="1" rowspan="1">Eukaryotic translation elongation factor 2</td>
<td align="left" colspan="1" rowspan="1">Protein translation</td>
<td align="left" colspan="1" rowspan="1">Loss‐of‐function</td>
<td align="left" colspan="1" rowspan="1">MM</td>
<td align="left" colspan="1" rowspan="1">Hekman <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0036">2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCA27/episodic ataxia</td>
<td align="left" colspan="1" rowspan="1">FGF14</td>
<td align="left" colspan="1" rowspan="1">Fibroblast growth factor 14</td>
<td align="left" colspan="1" rowspan="1">Modulation of Na<sub>v</sub> channels, signal transduction</td>
<td align="left" colspan="1" rowspan="1">Loss‐of‐function</td>
<td align="left" colspan="1" rowspan="1">MM, D</td>
<td align="left" colspan="1" rowspan="1">van Swieten <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0106">2003</xref>; Brusse <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0007">2006</xref>; Shakkottai <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0099">2009</xref>; Choquet <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0012">2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCA28</td>
<td align="left" colspan="1" rowspan="1">AFG3L2</td>
<td align="left" colspan="1" rowspan="1">ATPase family gene 3‐like 2</td>
<td align="left" colspan="1" rowspan="1">ATP‐dependent protease activity</td>
<td align="left" colspan="1" rowspan="1">Haplo‐insufficiency</td>
<td align="left" colspan="1" rowspan="1">MM, FM</td>
<td align="left" colspan="1" rowspan="1">Maltecca <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0067">2009</xref>: Di Bella <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0024">2010</xref>; Musova <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0074">2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCA35</td>
<td align="left" colspan="1" rowspan="1">TGM6</td>
<td align="left" colspan="1" rowspan="1">Transglutaminase</td>
<td align="left" colspan="1" rowspan="1">Modification of glutamine residues</td>
<td align="left" colspan="1" rowspan="1">Loss‐of‐function</td>
<td align="left" colspan="1" rowspan="1">ID, MM</td>
<td align="left" colspan="1" rowspan="1">Wang <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0108">2010</xref>: Guo <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0032">2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCA40</td>
<td align="left" colspan="1" rowspan="1">CCDC88C</td>
<td align="left" colspan="1" rowspan="1">Coiled‐coil domain containing protein 88C</td>
<td align="left" colspan="1" rowspan="1">JNK signalling</td>
<td align="left" colspan="1" rowspan="1">Gain‐of‐function</td>
<td align="left" colspan="1" rowspan="1">MM</td>
<td align="left" colspan="1" rowspan="1">Tsoi <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0104">2014</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tjp7081-tbl1-note-0001">
<p>DN, dominant‐negative; ID, in‐frame deletion; MM, missense mutation; FM, frame‐shift mutation; D, large deletion.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
</permissions>
</table-wrap>
<p>The focus of this review is genetic analyses and use of experimental models to elucidate the pathogenesis of spinocerebellar ataxia type 5 (SCA5). Evidence will be presented demonstrating how changes in Purkinje cell intrinsic excitability, dendritic architecture and synaptic function, observed in mouse models of SCA5, have contributed to our understanding of cerebellar dysfunction in SCA5 and how similar physiological defects may be associated with other SCAs.</p>
</sec>
<sec disp-level="2" id="tjp7081-sec-0030">
<title>Heterozygous mutations in <italic>SPTBN2</italic> gene give rise to spinocerebellar ataxia type 5</title>
<p>The genetic locus for SCA5 was mapped to the centromeric region of the long arm of chromosome 11 (11q13) using a large kindred descended from the paternal grandparents of United States President Abraham Lincoln (Ranum <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0090">1994</xref>). Later a French (Stevanin <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0102">1999</xref>) and a German (Burk <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0008">2004</xref>) pedigree with a similarly mild form of SCA were linked to the same chromosomal region. Mutations were subsequently identified in the <italic>SPTBN2</italic> gene encoding β‐III spectrin (Fig. <xref ref-type="fig" rid="tjp7081-fig-0001">1</xref>
<italic>A</italic>; Ikeda <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0044">2006</xref>), which is found throughout the cell body and dendritic tree of Purkinje cells (Jackson <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0048">2001</xref>).</p>
<fig fig-type="Figure" id="tjp7081-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<title>
<bold>Structure of β‐III spectrin and localisation of mutations</bold>
</title>
<p>
<italic>A</italic>, β‐III spectrin comprises an N‐terminal actin binding domain, 17 spectrin repeats and a pleckstrin homology (PH) domain at the C‐terminus, which can facilitate interaction with the lipid bilayer. Mutations associated with SCA5 are indicated: missense mutation (L253P) within second calponin‐homology (CH) domain, German family (Ikeda <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0044">2006</xref>); missense mutation (T472M) within second spectrin repeat, Norwegian family (Cho &amp; Fogel, <xref ref-type="ref" rid="tjp7081-bib-0011">2013</xref>); 39 bp in‐frame deletion (Δ39) resulting in 13‐amino‐acid deletion (E532_M544del) within third spectrin repeat, Lincoln pedigree (Ikeda <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0044">2006</xref>); 15 bp in‐frame deletion (L629_R634) and missense mutation (R634W), French family (Ikeda <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0044">2006</xref>); 3 bp in‐frame deletion resulting in glutamic acid deletion (E870del) in sixth spectrin repeat, Japanese family (Wang <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0110">2014</xref>). Co‐segregation of mutations N1224S, R1880H and E2804L with ataxia is uncertain (Zühlke <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0117">2007</xref>). <italic>B</italic>, location of mutations associated with infantile cerebellar ataxia: heterozygous R480W mutation identified in two cases of infantile ataxia with global developmental delay (Jacob <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0049">2012</xref>; Parolin Schnekenberg <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0079">2015</xref>); homozygous stop codon (C627X) within third spectrin repeat, UK family (Lise <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0063">2012</xref>); homozygous 5 bp frameshift deletion (T955ins120X) in spectrin repeat 6, Egyptian family (Elsayed <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0027">2014</xref>). Homozygous 8 bp frameshift deletion (G1952ins27X) in spectrin repeat 16, Beagle puppies (Forman <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0028">2012</xref>).</p>
</caption>
<graphic id="nlm-graphic-7" xlink:href="TJP-594-4661-g002"></graphic>
</fig>
<p>The initial symptoms of SCA5 are disturbance of gait, incoordination of limbs, abnormal eye movements and slurred speech. Yet age of onset is variable within families, starting between the second and seventh decade. Typically there is no reduction in lifespan, possibly due to the lack of bulbar paralysis which in other SCAs appears to result in a poorer ability to fight recurrent pneumonia (Zoghbi, <xref ref-type="ref" rid="tjp7081-bib-0116">1991</xref>) and patients remain ambulatory for several decades. Pathologically severe atrophy of the cerebellum is observed with magnetic resonance imaging (MRI) and autopsy examination shows significant Purkinje cell loss, shrinkage of the molecular layer, mild loss of granular neurons and empty basket fibres (Ikeda <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0044">2006</xref>).</p>
</sec>
<sec disp-level="2" id="tjp7081-sec-0040">
<title>Infantile ataxia and cognitive impairment associated with mutations in <italic>SPTBN2</italic>
</title>
<p>Homozygous mutations in <italic>SPTBN2</italic> were recently found in two families with both cerebellar ataxia from childhood and cognitive impairment (Fig. <xref ref-type="fig" rid="tjp7081-fig-0001">1</xref>
<italic>B</italic>), classifying an allelic condition, spectrin associated autosomal recessive cerebellar ataxia type 1 (SPARCA1) (Lise <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0063">2012</xref>; Elsayed <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0027">2014</xref>). A complete loss‐of β‐III spectrin function is thus implicated in motor and cognitive deficits from birth. However, a novel heterozygous mutation (R480W) has also been reported in a patient exhibiting infantile onset and global developmental delay (Jacob <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0049">2012</xref>). It may be that in this case there is an undetected mutation in <italic>trans</italic> or an environmental modifier resulting in a much earlier and more severe phenotype than other β‐III spectrin heterozygous mutations. Alternatively residue R480, within spectrin repeat 2, could be of particular structural importance. Notably, the same heterozygous R480W mutation was recently identified in a child originally given a working diagnosis of ataxia cerebral palsy (Parolin Schnekenberg <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0079">2015</xref>), strengthening the evidence that mutation R480W is more deleterious than other heterozygous <italic>SPTBN2</italic> mutations.</p>
<p>Variability in presentation has similarly been observed for mutations in other SCA‐associated loci. Mutations in the inositol 1,4,5‐trisphosphate receptor type 1 gene (<italic>ITPR1</italic>) have been reported in families with late onset SCA15 (van de Leemput <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0105">2007</xref>), early‐onset SCA29 (Iwaki <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0047">2008</xref>) and sporadic infantile‐onset cerebellar ataxia (Huang <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0041">2012</xref>). Mutations in the genes <italic>KCNC3</italic> (Waters <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0111">2006</xref>; Parolin Schnekenberg <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0079">2015</xref>) and <italic>FGF14</italic> (Coebergh <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0016">2014</xref>; Planes <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0084">2015</xref>) have also been associated with variable phenotypes. The molecular reason(s) for differences in timing of onset remain unknown, but the clinical characteristics of patients with early‐onset disease are generally non‐progressive ataxia, motor developmental delay and mild cognitive deficits. Understanding the molecular mechanisms whereby early‐onset cases of ataxia are associated with cognitive impairment could help address whether the cerebellum plays a developmental role in cognition or if the deficits are non‐cerebellar in origin.</p>
</sec>
<sec disp-level="2" id="tjp7081-sec-0050">
<title>Loss‐of protein function in cerebellar pathogenesis</title>
<p>Animal models have proved instrumental in elucidating the pathogenesis of SCA. To date three different SCA5 mouse models have been generated and analysed for signs of motor incoordination and cerebellar degeneration in relation to disrupted β‐III spectrin function (Table <xref ref-type="table-wrap" rid="tjp7081-tbl-0002">2</xref>). Two mouse models were created by gene disruption, one by exon trapping (Spnb3<sup>−/−</sup>; Stankewich <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0101">2010</xref>) and the other by targeted recombination (β‐III<sup>−/−</sup>; Perkins <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0081">2010</xref>). The third is a conditional transgenic model which utilises the tetracycline transactivator protein (tTA) under the control of the Purkinje cell specific promoter Pcp2 to specifically drive wild‐type or Δ39 β‐III spectrin in cerebellar Purkinje cells (Armbrust <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0003">2014</xref>). All three models exhibit motor impairment but only the β‐III<sup>−/−</sup> mouse model recapitulates the progressive motor deficits and Purkinje cell loss observed in SCA5 patients (Perkins <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0081">2010</xref>). The β‐III<sup>−/−</sup> mouse model in particular has implicated neuronal dysfunction in the early motor phenotype with gait and coordination deficits evident prior to any cerebellar degeneration. It, together with the identification of the allelic condition SPARCA1, has also provided insights into the molecular dominance in SCA5. Results suggest the disease is due to loss‐of‐function but not due to β‐III spectrin haploinsufficiency as no phenotype is observed in 2‐year‐old heterozygous (β‐III<sup>+/−</sup>) mice (Clarkson <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0014">2010</xref>) or elderly heterozygous SPARCA1 carriers (Lise <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0063">2012</xref>). Instead SCA5 pathogenesis is likely to occur when β‐III spectrin function falls below 50% of wild‐type level due to interference by mutant protein.</p>
<table-wrap id="tjp7081-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>Molecular, anatomical and behavioural characteristics of mouse lines generated to model SCA5</p>
</caption>
<table frame="hsides" rules="groups">
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="center" colspan="1" rowspan="1">Spnb3<sup>−/−</sup>
</th>
<th align="center" colspan="1" rowspan="1">β‐III<sup>−/−</sup>
</th>
<th align="center" colspan="1" rowspan="1">Pcp2‐tTA<sup>+/−</sup>/TRE‐SPΔ39<sup>+/−</sup>
</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1"></th>
<th align="center" colspan="1" rowspan="1">(Stankewich <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0101">2010</xref>)</th>
<th align="center" colspan="1" rowspan="1">(Perkins <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0081">2010</xref>)</th>
<th align="center" colspan="1" rowspan="1">(Armbrust <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0003">2014</xref>)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Protein expressed</td>
<td align="left" colspan="1" rowspan="1">Truncated β‐III spectrin, terminating at start of spectrin repeat 14</td>
<td align="left" colspan="1" rowspan="1">β‐III spectrin lacking exons 2–6 (actin binding domain)</td>
<td align="left" colspan="1" rowspan="1">Full complement of mouse β‐lll spectrin. Human Δ39β‐III spectrin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Protein distribution</td>
<td align="left" colspan="1" rowspan="1">Mislocalised to axon initial segment</td>
<td align="left" colspan="1" rowspan="1">Normal somatodendritic distribution</td>
<td align="left" colspan="1" rowspan="1">Normal somatodendritic distribution</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Motor defects</td>
<td align="left" colspan="1" rowspan="1">Slightly poorer performance on rotarod at 8 months of age. Not progressive</td>
<td align="left" colspan="1" rowspan="1">Progressive ataxia with mild motor impairment at 3 weeks of age. By 6 months of age unable to stay on rotarod at 3 r.p.m.</td>
<td align="left" colspan="1" rowspan="1">Mild impairment on rotarod at 26 weeks of age. Later time points not analysed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cerebellar degeneration</td>
<td align="left" colspan="1" rowspan="1">Thinning of molecular layer at 8 months. No PC loss at 1.5 years</td>
<td align="left" colspan="1" rowspan="1">ML thinning and PC loss visible by 6 months, greater at 1 year</td>
<td align="left" colspan="1" rowspan="1">Thinning of ML at 80 weeks. No PC loss</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Unexpected phenotype</td>
<td align="left" colspan="1" rowspan="1">Myoclonic seizures. Muscle weakness</td>
<td align="left" colspan="1" rowspan="1">None</td>
<td align="left" colspan="1" rowspan="1">None</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
</permissions>
</table-wrap>
<p>Loss‐of protein functions due to dominant‐negative effects have also been reported for a number of other SCA subtypes (Table <xref ref-type="table-wrap" rid="tjp7081-tbl-0001">1</xref>). Knock‐out animals therefore have the potential to mirror disease phenotypes of autosomal dominant SCAs more faithfully than transgenic models. However, full characterisation for the presence of truncated proteins that could either abrogate loss‐of protein function or confer an aberrant function is essential, as is functional analysis to validate models as true knockouts. Creation of representative transgenic models also requires, in order to avoid gene dosage effects on phenotype, detailed information regarding the stability and expression level of mutant proteins and the minimum level of wild‐type protein critical for normal function. This is highlighted by work using <italic>Drosophila</italic> models of SCA5 where progressive neurodegeneration was observed in the <italic>Drosophila</italic> eye when human β‐III spectrin containing either the German (L253P) or American (Δ39) mutation was ectopically overexpressed (Lorenzo <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0064">2010</xref>). The phenotype, however, was milder in flies hemizygous for L253P spectrin, with these flies expressing significantly lower levels of transgenic protein than flies expressing Δ39 spectrin. The phenotype could be enhanced by increasing L253P spectrin expression through creation of homozygous flies. Similarly posterior paralysis was only observed in larvae expressing a single copy of human Δ39 spectrin when one copy of the endogenous β‐spectrin gene was silenced. Hopefully with the advent of new gene targeting technologies (TALENs, Crispr/Cas9) the creation of knock‐in models will be greatly facilitated, circumventing caveats surrounding level of transgene expression for loss‐of‐function models.</p>
</sec>
<sec disp-level="2" id="tjp7081-sec-0060">
<title>Common molecular mechanisms underpinning cerebellar dysfunction in SCAs</title>
<p>Analyses of the different animal models and a number of <italic>in vitro</italic> studies have implicated various molecular mechanisms in the cerebellar dysfunction associated with SCA5. In particular they converge on alterations to glutamatergic transmission and Purkinje cell excitability, arising from a role for β‐III spectrin in membrane protein trafficking, localisation and stabilisation. Disruption to these same physiological processes is evident in models of other SCAs, highlighting the possible convergence of common mechanisms in cerebellar ataxia.</p>
<sec id="tjp7081-sec-0070">
<title>Disruption in membrane protein trafficking, localisation and/or stabilisation</title>
<p>The actin binding domain and C‐terminus of β‐III spectrin (Fig. <xref ref-type="fig" rid="tjp7081-fig-0002">2</xref>
<italic>A</italic>) were both shown in a yeast two‐hybrid assay to directly bind to Arp 1 (Holleran <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0037">2001</xref>), a subunit of the dynactin complex which mediates the association of vesicular cargo with the microtubule motor dynein (Karki <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0053">2000</xref>). Further support for β‐III spectrin's role in protein vesicular trafficking is the co‐purification from rat brain vesicles with Arp1 and dynein (Holleran <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0037">2001</xref>) and disruption to axonal transport in flies expressing either the American or German mutant β‐III spectrin, with enhancement of these transport abnormalities in dynein and dynactin loss‐of‐function mutants (Lorenzo <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0064">2010</xref>). Both β‐III spectrin knockout (Spnb3<sup>−/−</sup> and β‐III<sup>−/−</sup>) mouse lines also exhibit dilatation of endoplasmic reticulum and alterations to Golgi structure indicating an important function of β‐III spectrin in the trafficking of membrane proteins (Perkins <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0081">2010</xref>; Stankewich <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0101">2010</xref>).</p>
<fig fig-type="Figure" id="tjp7081-fig-0002" orientation="portrait" position="float" xml:lang="en">
<label>Figure 2</label>
<caption>
<title>
<bold>Defective protein trafficking when β‐III spectrin's scaffold of protein interactions is disrupted</bold>
</title>
<p>
<italic>A</italic>, schematic diagram depicting identified interacting partners of β‐III spectrin: Arp1, ankyrin R, mGluR1 and EAAT4. <italic>B</italic> and <italic>B</italic>′, full‐length (FL) EAAT4 located at cell membrane and in spine‐like protrusions when overexpressed in Neuro2a cells. <italic>C</italic> and <italic>C</italic>′, EAAT4 lacking β‐III spectrin's interacting domain within terminal 11 amino acids (EAAT4Δ11) is located peri‐nuclearly and in large intracellular vesicles. Scale bar: <italic>B</italic> and <italic>C</italic>, 20 μm; <italic>B</italic>′ and <italic>C</italic>′, 10 μm.</p>
</caption>
<graphic id="nlm-graphic-9" xlink:href="TJP-594-4661-g003"></graphic>
</fig>
<p>It has been shown that β‐III spectrin interacts directly with the carboxy‐terminus of EAAT4 (Fig. <xref ref-type="fig" rid="tjp7081-fig-0002">2</xref>
<italic>A</italic>; Jackson <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0048">2001</xref>), the glutamate transporter found in Purkinje cell soma and dendrites (Yamada <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0113">1996</xref>; Dehnes <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0022">1998</xref>). The interaction stabilises EAAT4 at the plasma membrane, resulting in an increase in cell surface expression and enhanced glutamate uptake (Jackson <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0048">2001</xref>). In contrast, mutant Δ39 β‐III spectrin failed to restrict the lateral mobility of EAAT4 in HEK 293 cells indicating an inability to properly anchor EAAT4 at the plasma membrane (Ikeda <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0044">2006</xref>). Co‐expression of mutant L253P β‐III spectrin in HEK 293 cells was also found to disrupt post‐Golgi trafficking of EAAT4, with normal cell surface expression only attainable when cells were incubated at a lower temperature (Clarkson <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0014">2010</xref>). Similarly, EAAT4 lacking the terminal 11 amino acids and hence the β‐III spectrin binding motif, remains peri‐nuclear or in large intracellular vesicular structures when expressed in Neuro2a (Fig. <xref ref-type="fig" rid="tjp7081-fig-0002">2</xref>
<italic>C</italic>). In contrast full length EAAT4 is present at the cell surface in Neuro2a cells enriched in spine‐like protrusions (Fig. <xref ref-type="fig" rid="tjp7081-fig-0002">2</xref>
<italic>B</italic>). Together these <italic>in vitro</italic> findings support an important role for β‐III spectrin in the cellular trafficking and stabilisation of EAAT4 at the plasma membrane. Importantly, reduced EAAT4 levels were observed in young β‐III<sup>−/−</sup> and Spnb3<sup>−/−</sup> mice with EAAT4 accumulating in the cell soma and dendritic shafts (Perkins <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0081">2010</xref>; Stankewich <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0101">2010</xref>; Gao <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0029">2011</xref>), similar to SCA5 autopsy tissue (Ikeda <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0044">2006</xref>). Loss of EAAT4 and β‐III spectrin prior to onset of symptoms was also reported in a transgenic mouse model of SCA1 that specifically expresses in Purkinje cells human ataxin‐1 with a pathological (82) polyglutamine repeat length (ATXN1<sup>Q82</sup>) (Lin <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0062">2000</xref>; Serra <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0096">2004</xref>). More direct evidence that EAAT4 loss is causal in cerebellar dysfunction comes from recent analyses of EAAT4 knockout animals which were found to exhibit motor deficits prior to cerebellar degeneration (unpublished data). No early loss of EAAT4 was observed in the SCA5 transgenic model, but this may be a consequence of the low expression level of Δ39 β‐III spectrin transgene (Armbrust <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0003">2014</xref>).</p>
<p>Expression and stability of other membrane proteins have also been reported to be dependent on β spectrin. A decrease in two cell adhesion molecules, neuroglian and Fasciclin II (Fas II), was observed in <italic>Drosophila</italic> lacking presynaptic β spectrin (Pielage <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0083">2005</xref>) and an altered distribution of Fas II was seen in flies expressing SCA5 mutant spectrin (Lorenzo <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0064">2010</xref>). Recently β‐III spectrin repeats 14–16 were shown to interact with the metabotropic glutamate receptor mGluR1α and TIRF microscopy revealed wild‐type but not mutant Δ39 β‐III spectrin could increase the stability of mGluR1α–green fluorescent protein (GFP) at the plasma membrane (Armbrust <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0003">2014</xref>). The recruitment and maintenance of ankyrin R at the plasma membrane of Purkinje cell dendrites also seems to depend on β‐III spectrin (Clarkson <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0015">2014</xref>), and further direct evidence for the importance of this interaction in SCA pathogenesis comes from normoblastosis (<italic>nb</italic>/<italic>nb</italic>) mice, deficient in erythroid ankyrin, which develop abnormal gait, tremor and 50% loss of Purkinje cells by the age of 6 months (Peters <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0082">1991</xref>).</p>
<p>β‐III spectrin is not believed to be expressed in Bergmann glia, but loss of the glial glutamate transporter GLAST (EAAT1 in humans) was observed in both Spnb3<sup>−/−</sup>(Stankewich <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0101">2010</xref>) and β‐III<sup>−/−</sup> (Perkins <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0081">2010</xref>) mouse lines, indicating an indirect effect on glial membrane protein stability, possibly arising from disruption to cell–cell adhesion and signalling molecules. In β‐III<sup>−/−</sup> mice the decrease in GLAST has been implicated in the progression of motor deficits (Perkins <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0081">2010</xref> and unpublished data) and correlations between decreased GLAST expression and Purkinje cell loss were also reported for transgenic ATXN1<sup>Q82</sup> SCA1 mice (Cvetanovic, <xref ref-type="ref" rid="tjp7081-bib-0019">2015</xref>) and mice expressing, only in Bergmann glia, mutant ataxin 7 protein (Custer <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0018">2006</xref>). Understanding the mechanisms that underpin loss of GLAST will be important as these may highlight potential strategies for mitigating disease progression. There is also evidence that loss of EAAT1 is a primary cause of ataxia with mutations in <italic>SLC1A3</italic>, the gene encoding excitatory amino acid transporter 1, giving rise to episodic ataxia (Jen <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0050">2005</xref>; de Vries <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0023">2009</xref>), further supporting the idea that loss of GLAST is more than a simple consequence of a different primary genetic defect.</p>
</sec>
<sec id="tjp7081-sec-0080">
<title>Changes to intrinsic Purkinje cell activity</title>
<p>A key component of Purkinje cell output is their intrinsic activity, which has been found in <italic>in vitro</italic> electrophysiological recordings to be altered in various SCA models (Table <xref ref-type="table-wrap" rid="tjp7081-tbl-0003">3</xref> and Fig. <xref ref-type="fig" rid="tjp7081-fig-0003">3</xref>). It is governed by specific ion channels and in particular Na<sub>v</sub>1.1 and 1.6 channels, the two dominant Na<sub>v</sub> channels in cerebellar Purkinje neurons, both of which possess a resurgent sodium current (Raman &amp; Bean, <xref ref-type="ref" rid="tjp7081-bib-0088">1997</xref>; Raman <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0089">1997</xref>; Khaliq <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0055">2003</xref>; Kalume <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0052">2007</xref>). Sodium channel dysfunction was observed in the β‐III<sup>−/−</sup> mouse model of SCA5 prior to cerebellar atrophy with smaller whole‐cell and resurgent sodium currents recorded from dissociated Purkinje cells isolated from P16–P20 β‐III<sup>−/−</sup> mice (Fig. <xref ref-type="fig" rid="tjp7081-fig-0004">4</xref>; Perkins <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0081">2010</xref>). This is consistent with the slower rate of Purkinje cell tonic firing observed in cerebellar slices from 3‐week‐old β‐III<sup>−/−</sup> mice (Fig. <xref ref-type="fig" rid="tjp7081-fig-0003">3</xref>
<italic>B</italic>; Perkins <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0081">2010</xref>) and may well be a consequence of decreased Na<sub>v</sub>1.1 and 1.6 stability in the absence of a β‐III spectrin/ankyrin R anchor (Clarkson <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0015">2014</xref>). Functional <italic>in vitro</italic> analyses of two SCA5‐associated mutant β‐III spectrin proteins (L253P and R634W) also showed diminished effects in enhancing sodium currents compared to wild‐type β‐III spectrin with reduced ankyrin R and Na<sub>v</sub> channel levels associated with this effect (Clarkson <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0015">2014</xref>). Together the data indicate that reduced Purkinje cell intrinsic activity due to a decreased stability of the β‐III spectrin/ankyrin‐R/Na<sub>v</sub> complex is likely to be a critical component of SCA5 pathogenesis. The heterozygous R480W mutation associated with infantile ataxia was found to have a similar effect to the L253P and R634W mutants (Parolin Schnekenberg <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0079">2015</xref>) and so additional structural and expression studies are required to resolve whether the change of arginine to tryptophan at reside 480 is more physiologically deleterious than the other heterozygous mutations so far characterised.</p>
<table-wrap id="tjp7081-tbl-0003" orientation="portrait" position="float" xml:lang="en">
<label>Table 3</label>
<caption>
<p>Common Purkinje cell intrinsic activity defects in models of SCA</p>
</caption>
<table frame="hsides" rules="groups">
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<thead>
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1">SCA subtype</th>
<th align="center" colspan="1" rowspan="1">Physiological deficit</th>
<th align="center" colspan="1" rowspan="1">Molecular mechanism</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">SCA1</td>
<td align="left" colspan="1" rowspan="1">Reduced intrinsic firing frequency. Irregular plateau potential</td>
<td align="left" colspan="1" rowspan="1">Increased K<sub>v</sub>4.3 surface expression</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCA2</td>
<td align="left" colspan="1" rowspan="1">Reduced intrinsic firing frequency</td>
<td align="left" colspan="1" rowspan="1">Increased Ca<sup>2+</sup> release from intracellular stores</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCA3</td>
<td align="left" colspan="1" rowspan="1">Purkinje cells either silent through depolarisation block or display faster intrinsic firing rate/burst firing</td>
<td align="left" colspan="1" rowspan="1">Increased K<sub>v</sub>3 channel inactivation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCA5</td>
<td align="left" colspan="1" rowspan="1">Reduced intrinsic firing frequency</td>
<td align="left" colspan="1" rowspan="1">Decrease in whole‐cell and resurgent sodium current</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCA13</td>
<td align="left" colspan="1" rowspan="1">Reduced intrinsic firing frequency. Broader action potential</td>
<td align="left" colspan="1" rowspan="1">Decrease in K<sub>v</sub>3.3 activity</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCA27</td>
<td align="left" colspan="1" rowspan="1">Reduced intrinsic firing frequency</td>
<td align="left" colspan="1" rowspan="1">Decrease in resurgent sodium</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">or Purkinje cells silent</td>
<td align="left" colspan="1" rowspan="1">current</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
</permissions>
</table-wrap>
<fig fig-type="Figure" id="tjp7081-fig-0003" orientation="portrait" position="float" xml:lang="en">
<label>Figure 3</label>
<caption>
<title>
<bold>Intrinsic activity of Purkinje cells altered in mouse models of SCA</bold>
</title>
<p>
<italic>A</italic>, representative trace of a current‐clamp <italic>in vitro</italic> slice recording for a spontaneously firing Purkinje cell. <italic>B</italic>, slower firing rates compared to controls observed in models of SCA1, 2, 5, 13 and 27. <italic>C</italic>, quiescent Purkinje cells identified in SCA3 and 27 models, about one‐half and 80% of cells, respectively. <italic>D</italic>, faster tonic firing rate and burst firing observed in remaining SCA3 tg/– Purkinje cells.</p>
</caption>
<graphic id="nlm-graphic-11" xlink:href="TJP-594-4661-g004"></graphic>
</fig>
<fig fig-type="Figure" id="tjp7081-fig-0004" orientation="portrait" position="float" xml:lang="en">
<label>Figure 4</label>
<caption>
<title>
<bold>Smaller sodium currents are likely to underpin reduced intrinsic activity</bold>
</title>
<p>
<italic>A</italic>, representative current traces from acutely dissociated Purkinje cells elicited with a step depolarisation to −30 mV from a holding potential of −90 mV. <italic>B</italic>, resurgent sodium currents evoked using a 20 ms step to +30 mV, from a holding potential of –90 mV, followed by repolarisation to −30 mV. Top traces are from wild‐type Purkinje cells and bottom traces from β‐III<sup>−/−</sup> Purkinje cells showing reduced whole cell Na<sup>+</sup> currents and absence of resurgent currents.</p>
</caption>
<graphic id="nlm-graphic-13" xlink:href="TJP-594-4661-g005"></graphic>
</fig>
<p>A similar decrease in Purkinje cell excitability resulting from sodium channel dysfunction was reported for SCA27 pathogenesis, the genetic causes of which are two loss‐of‐function mutations, a point mutation (F145S) or a frameshift mutation (Asp163fsX12), in the intracellular fibroblast growth factor 14 (iFGF14) gene (Wang <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0109">2002</xref>; van Swieten <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0106">2003</xref>; Dalski <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0020">2005</xref>). iFGFs bind directly to the cytoplasmic C‐terminal domains of Na<sub>v</sub> channel α subunits, with wild‐type FGF14 increasing Na<sub>v</sub> current densities in hippocampal neurones (Lou <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0065">2005</xref>), whereas peak sodium currents were reduced in cells expressing SCA27 disease associated mutation FGF14<sup>F145S</sup> (Laezza <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0060">2007</xref>). It is thought that FGF14 functions as an oligomeric protein and FGF14<sup>F145S</sup> acts as a dominant negative disrupting the association of wild‐type FGF14 and Na<sub>v</sub> channel α subunits. Such a role for loss‐of‐Nav channel modulation and decreased neuronal excitability in SCA27 pathogenesis is supported by the absence <italic>in vitro</italic> of spontaneous activity in Purkinje cells both from FGF14‐null mice (Shakkottai <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0099">2009</xref>), which exhibit a very similar phenotype to that of SCA27 patients and following <italic>in vivo</italic> iFGF14 knock‐down studies (Bosch <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0005">2015</xref>). Reduced Na<sub>v</sub> resurgent sodium current amplitudes and spontaneous firing rates were also observed following acute knockdown of iFGF14 in cultured Purkinje cells (Yan <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0114">2014</xref>). A key feature of SCA27 pathogenesis appears to be enhanced Na<sub>v</sub> channel inactivation and loss of resurgent current downstream of FGF14 loss‐of‐function.</p>
<p>K<sub>v</sub>3 channels are also indispensable for high‐frequency intrinsic firing as they exhibit fast activation and deactivation kinetics. Missense mutations (R420H, R423H and F448L) in the gene encoding human K<sub>v</sub>3.3 (<italic>KCNC3</italic>) give rise to SCA13 (Waters <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0111">2006</xref>; Irie <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0046">2014</xref>). Since all K<sub>v</sub> channels are formed by the assembly of four subunits, K<sub>v</sub>3.3 channels in SCA13 are likely to consist of WT and mutant subunits with normal function being disrupted in a dominant‐negative manner. This is supported by the fact smaller outward currents, broadened action potential wave‐forms and a reduced firing frequency are observed in cultured Purkinje cells expressing mouse K<sub>v</sub>3.3–R424H (Irie <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0046">2014</xref>), the equivalent of human R423H, similar to <italic>in vitro</italic> recordings from K<sub>v</sub>3.3 knockout mice (Hurlock <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0042">2008</xref>). The resulting delay in Purkinje cell repolarisation is thought to instigate cell death by increasing Ca<sup>2+</sup> influx through excessive activation of Ca<sub>v</sub> channels.</p>
<p>Mutations giving rise to SCA19/22 were also recently identified in another K<sub>v</sub> subunit, K<sub>v</sub>4.3, and are predicted to reduce cerebellar output, similar to SCA13, as they impair trafficking of the channel to the plasma membrane and/or reduce channel activity (Duarri <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0026">2012</xref>; Lee <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0061">2012</xref>). In contrast, accumulation of K<sub>v</sub>4.3 channels at the cell surface was observed in the SCA1 ATXN1<sup>Q82</sup> mouse model (Hourez <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0040">2011</xref>). Five‐week‐old ATXN1<sup>Q82</sup> mice displayed impaired motor performance and reduced <italic>in vitro</italic> firing frequencies, with a proportion of cells showing an irregular plateau potential, but no cell atrophy or death at this age. Both the firing frequency and the motor performance were restored by treatment with DiAP, a potassium channel blocker. The molecular mechanisms underlying the increase in K<sub>v</sub>4.3 surface expression and mode of DiAP action are not yet fully understood, although the former is suggested to be linked to reduced K<sub>v</sub> internalisation due to smaller glutamate receptor‐mediated postsynaptic currents.</p>
<p>Alterations to Purkinje cell firing prior to signs of neurodegeneration were also observed in <italic>in vitro</italic> slice recordings for mouse models of SCA3 with 84 glutamine repeats in the <italic>ATXN3</italic> gene (Shakkottai <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0098">2011</xref>) and SCA2 with 127 glutamine repeats in human ataxin‐2 cDNA (Hansen <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0033">2013</xref>). About one half of the SCA3 tg/− Purkinje cells were found to be silent, with a depolarised membrane potential and the others either displayed a faster firing rate than wild‐type or exhibited repetitive bursts demonstrating increased excitability (Fig. <xref ref-type="fig" rid="tjp7081-fig-0003">3</xref>
<italic>D</italic>). Depolarisation block, through increased K<sub>v</sub>3 current inactivation, was reported to give rise to the loss of repetitive firing, but how mutant ataxin‐3 alters K<sub>v</sub>3 channel kinetics is not known. One possibility is that it affects the post‐translational modification of potassium channels. In the case of <italic>ATXN2</italic>
<sup>Q127</sup> mice a progressive slowing in the firing rate was observed with age but additional analyses are required to determine the molecular mechanisms responsible.</p>
</sec>
<sec id="tjp7081-sec-0090">
<title>Altered Purkinje cell dendritic architecture</title>
<p>Cerebellar output is also influenced by the integration of excitatory and inhibitory inputs that modulate intrinsic Purkinje cell activity (Hausser &amp; Clark, <xref ref-type="ref" rid="tjp7081-bib-0034">1997</xref>). Since the elaborate monoplanar Purkinje cell dendritic tree determines both the number and type of input and how the synaptic signals decay as they propagate towards the soma (Rall, <xref ref-type="ref" rid="tjp7081-bib-0087">1977</xref>; Hausser <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0035">2000</xref>; Gulledge <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0031">2005</xref>), alterations to dendritic morphology will affect Purkinje cell output. In young β‐III<sup>−/−</sup> mice the Purkinje cell dendritic trees were found to be disordered and no longer planar, and dendrites were thinner (Fig. <xref ref-type="fig" rid="tjp7081-fig-0005">5</xref>; Gao <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0029">2011</xref>). Membrane properties are affected by dendritic diameter (Rall, <xref ref-type="ref" rid="tjp7081-bib-0087">1977</xref>) and so aberrant activation of low voltage‐gated calcium channels and excessive calcium entry, a potential consequence of thinner dendrites, may contribute to neuronal dysfunction. Loss of planarity prior to cell death can also alter synaptic inputs through interdigitation of neighbouring dendritic trees. Multiple climbing fibre (CF) innervation can arise via CF transverse branches (Miyazaki &amp; Watanabe, <xref ref-type="ref" rid="tjp7081-bib-0073">2011</xref>) and disruption to the specificity of granule cell input can occur through ascending axons making synaptic contact with more than one Purkinje cell and/or parallel fibres making additional contacts with the same Purkinje cell (Napper &amp; Harvey, <xref ref-type="ref" rid="tjp7081-bib-0076">1988</xref>).</p>
<fig fig-type="Figure" id="tjp7081-fig-0005" orientation="portrait" position="float" xml:lang="en">
<label>Figure 5</label>
<caption>
<title>
<bold>Early morphological changes to Purkinje cell dendritic architecture implicated in neuronal dysfunction</bold>
</title>
<p>Individual Purkinje cells from 6‐week‐old WT (<italic>A</italic>) and β‐III<sup>−/−</sup> (<italic>B</italic>) animals filled with Alexa Fluor 568 and imaged at Nyquist sampling rates (Scale bar, 20 μm). Thinner, disordered branching and greater dendritic protrusion in coronal plane evident in Purkinje cells lacking β‐III spectrin. Morphological changes can result in changes to resting membrane potential and number and/or specificity of synaptic inputs.</p>
</caption>
<graphic id="nlm-graphic-15" xlink:href="TJP-594-4661-g006"></graphic>
</fig>
<p>Changes to Purkinje cell dendritic architecture were also reported for Purkinje cells in an SCA3 mouse model expressing N‐terminally truncated <italic>ATXN3<sup>Q69</sup></italic> protein (Konno <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0058">2014</xref>) and for a cellular model of SCA14 (Seki <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0095">2009</xref>), which is caused by missense mutations in the <italic>PRKCG</italic> gene encoding protein kinase Cγ (PKCγ). Expression of either mutant S119P or G128D PKCγ in cultured Purkinje cells resulted in reduced dendritic area, dendrite diameter and spine density (Seki <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0095">2009</xref>). Conventional PKCs require Ca<sup>2+</sup> for activation and can regulate actin cytoskeleton dynamics through modulation of adducin and recruitment of spectrin to the ends of actin filaments (Matsuoka <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0070">1998</xref>). Morphological changes could be a common feature in a number of SCAs due to dysregulated Ca<sup>2+</sup> homeostasis and downstream effects on PKC activity and cytoskeletal dynamics.</p>
</sec>
<sec id="tjp7081-sec-0100">
<title>Defects in glutamatergic neurotransmission</title>
<p>Purkinje cells, due to the large amount of afferent glutamatergic input they receive from both parallel and climbing fibres through activation of ionotropic AMPA and metabotropic (mGluRs) receptors, are especially vulnerable to glutamate‐mediated excitotoxicity and elevations in intracellular calcium (Fig. <xref ref-type="fig" rid="tjp7081-fig-0006">6</xref>). Aberrant glutamatergic neurotransmission has been observed in two of the SCA5 mouse models. Enhanced parallel fibre‐mediated excitatory postsynaptic currents (PF‐EPSCs) were recorded from young β‐III<sup>−/−</sup> mice compared to wild‐type mice (Fig. <xref ref-type="fig" rid="tjp7081-fig-0006">6</xref>
<italic>A</italic> and <italic>B</italic>; Perkins <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0081">2010</xref>). Although initially the increase in excitability is thought to partially offset the reduced spontaneous activity, the excessive activation of AMPA receptors would appear to be ultimately detrimental, with Purkinje cells from 8‐month and older animals found to exhibit dendritic degeneration, undergo dark cell degeneration (Fig. <xref ref-type="fig" rid="tjp7081-fig-0006">6</xref>C) and have reduced <italic>in vivo</italic> output (Perkins <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0081">2010</xref>).</p>
<fig fig-type="Figure" id="tjp7081-fig-0006" orientation="portrait" position="float" xml:lang="en">
<label>Figure 6</label>
<caption>
<title>
<bold>Excessive glutamatergic innervation and AMPA receptor‐mediated delayed excitotoxicity in Purkinje cell degeneration</bold>
</title>
<p>
<italic>A</italic>, parallel fibre‐mediated Purkinje cell postsynaptic excitatory currents (PF‐EPSCs) measured by applying a stimulus within the molecular layer. <italic>B</italic>, greater excitability in Purkinje cells from 3‐ to 6‐week‐old β‐III<sup>−/−</sup> animals compared to WT animals shown by larger PF‐mediated EPSC amplitude. <italic>C</italic>, individually filled Purkinje cells reveal dendritic degeneration and ultrastructural analysis using transmission electron microscopy demonstrates dark cell degeneration in Purkinje cells from 8‐month‐old β‐III<sup>−/−</sup> but not WT animals. Dilatation of endoplasmic reticulum (ER), ER denuded of ribosomes (arrowhead) and fragmentation of Golgi (arrow) are all features of AMPA receptor‐elicited delayed excitotoxicity. Scale bar: top panel, 20 μm; bottom panel, 0.5 μm).</p>
</caption>
<graphic id="nlm-graphic-17" xlink:href="TJP-594-4661-g007"></graphic>
</fig>
<p>The glutamatergic defect detected in the SCA5 transgenic model is reduced mGluR1 activity following parallel fibre stimulation, due to mislocalisation but not loss of mGluR1 protein (Armbrust <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0003">2014</xref>). Impairment of mGluR1 signalling was also reported in the <italic>ATXN3<sup>Q69</sup></italic> mouse model (Konno <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0058">2014</xref>). A similar loss of mGluR1 signalling may not be detected in the two SCA5 knock‐out models as unlike the transgenic animals they both exhibit a loss of EAAT4 protein. EAAT4 modulates the activation of perisynaptic mGluRs, with high EAAT4 expressing Purkinje cells exhibiting very little mGluR activity (Wadiche &amp; Jahr, <xref ref-type="ref" rid="tjp7081-bib-0107">2005</xref>). Loss of EAAT4 in Spn3<sup>−/−</sup> and β‐III<sup>−/−</sup>, as well as ATXN1<sup>Q82</sup> mice may therefore result in excessive mGluR activation and downstream dysregulated calcium homeostasis. This would be similar to recent findings in a mouse model of SCA28, which is haploinsufficient for Afg3l2 and displays dark cell degeneration of Purkinje cells (Maltecca <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0067">2009</xref>). Reducing mGluR1 activity was found to decrease Ca<sup>2+</sup> levels in Afg3l2<sup>+/−</sup> Purkinje cells and reverse the ataxic phenotype (Maltecca <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0066">2015</xref>) indicating attenuating mGluR1 signalling may possess therapeutic promise.</p>
<p>The generation and analyses of various SCA mouse models has revealed possible common physiological deficits downstream of different primary genetic defects. Alterations to intrinsic firing through either direct or indirect effects on ion channels critical for maintaining fast repetitive Purkinje cell firing have been observed in the early stages of cerebellar ataxia in a number of SCA models. The majority of these studies have utilised <italic>in vitro</italic> slice recordings and so in the future it may be informative to assess the cerebellar output in awake animals. Alterations to Purkinje cell Ca<sup>2+</sup> homeostasis, in a number of instances arising from altered glutamatergic transmission, are another mechanism common across SCAs which could contribute to dysregulated PKC activity, cytoskeletal alterations, aberrant dendritic architecture and ultimately cell death.</p>
</sec>
</sec>
<sec disp-level="2" id="tjp7081-sec-0110">
<title>Summary</title>
<p>Cerebellar ataxias can all be characterised by the same clinical features (postural abnormalities, progressive motor incoordination and cerebellar degeneration) highlighting that although the underlying primary genetic defects differ, the downstream molecular mechanisms are likely to converge, with the ultimate effect of altered cerebellar output being common to all. Studies outlined in this review have identified alterations to intrinsic Purkinje cell excitability, dendritic morphology and glutamatergic transmission, arising from disruption to membrane protein trafficking, localisation and stabilisation, as factors pertinent to altered cerebellar output following loss of β‐III spectrin function. The necessity for orchestration of protein networks in normal cerebellar physiology is exemplified by the disruption of β‐III spectrin function and demonstrates how it is possible that defects in different components of a protein network can instigate the same pathogenic pathway.</p>
<p>Given that motor and cognitive decline are associated with normal ageing, a key question is whether changes to the spectrin submembranous meshwork and key membrane proteins might underpin age‐related changes in performance. It has been reported that a progressive increase in α‐II spectrin proteolysis (Cai <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0009">2012</xref>; Hwang <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0043">2012</xref>), a calcium‐dependent process linked to Purkinje cell toxicity (Mansouri <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0068">2007</xref>), is associated with age. Dilatation of the endoplasmic reticulum and degeneration of the Golgi apparatus (Dlugos, <xref ref-type="ref" rid="tjp7081-bib-0025">2005</xref>), reduction in glutamate transporters and functional glutamate uptake associated with mGluR activation (Potier <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0085">2010</xref>; Brothers <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0006">2013</xref>; Pereira <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0080">2014</xref>) as well as changes to the distribution of Na<sub>v</sub> channels (Chung <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0013">2003</xref>) have also all been reported in aged rodents. Dysregulation of glutamatergic neurotransmission and Purkinje cell excitability may therefore be an important feature of age‐related cerebellar decline. Similarly cerebellar abnormalities have also been linked to the pathophysiology of Alzheimer's disease (Sjöbeck &amp; Englund, <xref ref-type="ref" rid="tjp7081-bib-0100">2001</xref>; Mavroudis <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0072">2013</xref>), schizophrenia (Andreasen &amp; Pierson, <xref ref-type="ref" rid="tjp7081-bib-0002">2008</xref>), autism (Courchesne <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0017">1994</xref>; Palmen <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0078">2004</xref>; Whitney <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0112">2008</xref>) and other cognitive and neuropsychiatric disorders (Schmahmann &amp; Sherman, <xref ref-type="ref" rid="tjp7081-bib-0094">1998</xref>; Konarski <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0057">2005</xref>; Alalade <italic>et al</italic>. <xref ref-type="ref" rid="tjp7081-bib-0001">2011</xref>; Stoodley &amp; Stein <xref ref-type="ref" rid="tjp7081-bib-0103">2011</xref>). The ongoing challenge for researchers will be to decipher subtle changes in the morphological and molecular integrity of the cerebellar cortex that underpin Purkinje cell dysfunction both in early stages of various neurological disorders and in normal ageing.</p>
</sec>
<sec id="tjp7081-sec-0120">
<title>Additional information</title>
<sec id="tjp7081-sec-0130">
<title>Competing interests</title>
<p>None of the authors has any conflicts of interest.</p>
</sec>
<sec id="tjp7081-sec-0140">
<title>Author contributions</title>
<p>All authors have approved the final version of the manuscript and agree to be accountable for all aspects of the work. All persons designated as authors qualify for authorship, and all those who qualify for authorship are listed.</p>
</sec>
<sec id="tjp7081-sec-0150">
<title>Funding</title>
<p>The Wellcome Trust (EP &amp; MJ) and Ataxia UK/RS MacDonald Charitable Trust (DS).
</p>
</sec>
</sec>
</body>
<back>
<bio id="d36e59">
<p>
<bold>Emma Perkins</bold> did her PhD with Phil Larkman and remained at The University of Edinburgh to carry out postdoctoral work with Mandy Jackson. She has recently joined the Centre for Clinical Brain Sciences working with David Wyllie and Siddharthan Chandran.</p>
<graphic id="nlm-graphic-1" orientation="portrait" position="anchor" xlink:href="TJP-594-4661-g001.gif"></graphic>
</bio>
<bio id="d36e77">
<p>
<bold>Daumante Suminaite</bold> is currently writing up her PhD, supervised by Mandy Jackson and funded by Ataxia UK/RS MacDonald Charitable Trust.</p>
</bio>
<bio id="d36e94">
<p>
<bold>Mandy Jackson</bold> received her DPhil from the University of Oxford and then carried out a postdoctoral fellowship at Johns Hopkins University in the laboratory of Jeffrey Rothstein, before returning to The University of Edinburgh. Since 2013 she has been a senior lecturer within the School of Biomedical Sciences and the main research focus of her group is the investigation of molecular mechanisms underpinning cerebellar dysfunction.</p>
</bio>
<ref-list id="tjp7081-bibl-0001">
<title>References</title>
<ref id="tjp7081-bib-0001">
<mixed-citation id="tjp7081-cit-0001" publication-type="journal">
<string-name>
<surname>Alalade</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Denny</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Potter</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Steffens</surname>
<given-names>D</given-names>
</string-name> &amp; <string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name> (<year>2011</year>). <article-title>Altered cerebellar‐cerebral functional connectivity in geriatric depression</article-title>. <source/>PLoS One
<volume>6</volume>, <fpage>e20035</fpage>.<pub-id pub-id-type="pmid">21637831</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0002">
<mixed-citation id="tjp7081-cit-0002" publication-type="journal">
<string-name>
<surname>Andreasen</surname>
<given-names>NC</given-names>
</string-name> &amp; <string-name>
<surname>Pierson</surname>
<given-names>R</given-names>
</string-name> (<year>2008</year>). <article-title>The role of the cerebellum in schizophrenia</article-title>. <source/>Biol Psychiatry
<volume>64</volume>, <fpage>81</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="pmid">18395701</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0003">
<mixed-citation id="tjp7081-cit-0003" publication-type="journal">
<string-name>
<surname>Armbrust</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Hathorn</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Cramer</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Zu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kangas</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Zink</surname>
<given-names>AN</given-names>
</string-name>, <string-name>
<surname>Öz</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Ebner</surname>
<given-names>TJ</given-names>
</string-name> &amp; <string-name>
<surname>Ranum</surname>
<given-names>LP</given-names>
</string-name> (<year>2014</year>). <article-title>Mutant β‐III spectrin causes mGluR1α mislocalization and functional deficits in a mouse model of spinocerebellar ataxia type 5</article-title>. <source/>J Neurosci
<volume>34</volume>, <fpage>9891</fpage>–<lpage>9904</lpage>.<pub-id pub-id-type="pmid">25057192</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0004">
<mixed-citation id="tjp7081-cit-0004" publication-type="journal">
<string-name>
<surname>Bakalkin</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Watanabe</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Jezierska</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Depoorter</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Verschuuren‐Bemelmans</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Bazov</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Artemenko</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Yakovleva</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Dooijes</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Van de Warrenburg</surname>
<given-names>BP</given-names>
</string-name>, <string-name>
<surname>Zubarev</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Kremer</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Knapp</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Hauser</surname>
<given-names>KF</given-names>
</string-name>, <string-name>
<surname>Wijmenga</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Nyberg</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Sinke</surname>
<given-names>RJ</given-names>
</string-name> &amp; <string-name>
<surname>Verbeek</surname>
<given-names>DS</given-names>
</string-name> (<year>2010</year>). <article-title>Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23</article-title>. <source/>Am J Hum Genet
<volume>87</volume>, <fpage>593</fpage>–<lpage>603</lpage>.<pub-id pub-id-type="pmid">21035104</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0005">
<mixed-citation id="tjp7081-cit-0005" publication-type="journal">
<string-name>
<surname>Bosch</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Carrasquillo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ransdell</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Kanakamedala</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ornitz</surname>
<given-names>DM</given-names>
</string-name> &amp; <string-name>
<surname>Nerbonne</surname>
<given-names>JM</given-names>
</string-name> (<year>2015</year>). <article-title>Intracellular FGF14 (iFGF14) is required for spontaneous and evoked firing in cerebellar Purkinje neurons and for motor coordination and balance</article-title>. <source/>J Neurosci
<volume>35</volume>, <fpage>6752</fpage>–<lpage>6769</lpage>.<pub-id pub-id-type="pmid">25926453</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0006">
<mixed-citation id="tjp7081-cit-0006" publication-type="journal">
<string-name>
<surname>Brothers</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Bardou</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Hopp</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Kaercher</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Corona</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>Fenn</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Godbout</surname>
<given-names>JP</given-names>
</string-name> &amp; <string-name>
<surname>Wenk</surname>
<given-names>GL</given-names>
</string-name> (<year>2013</year>). <article-title>Riluzole partially rescues age‐associated, but not LPS‐induced, loss of glutamate transporters and spatial memory</article-title>. <source/>J Neuroimmune Pharmacol
<volume>8</volume>, <fpage>1098</fpage>–<lpage>1105</lpage>.<pub-id pub-id-type="pmid">23709339</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0007">
<mixed-citation id="tjp7081-cit-0007" publication-type="journal">
<string-name>
<surname>Brusse</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>de Koning</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Maat‐kievit</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Oostra</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Heutink</surname>
<given-names>P</given-names>
</string-name> &amp; <string-name>
<surname>van Swieten</surname>
<given-names>JC</given-names>
</string-name> (<year>2006</year>). <article-title>Spinocerebellar ataxia associated with a mutation in the fibroblast growth factor 14 gene (SCA27): a new phenotype</article-title>. <source/>Mov Disord
<volume>21</volume>, <fpage>396</fpage>–<lpage>401</lpage>.<pub-id pub-id-type="pmid">16211615</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0008">
<mixed-citation id="tjp7081-cit-0008" publication-type="journal">
<string-name>
<surname>Bürk</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Zühlke</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>König</surname>
<given-names>IR</given-names>
</string-name>, <string-name>
<surname>Ziegler</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Schwinger</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Globas</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Dichgans</surname>
<given-names>J</given-names>
</string-name> &amp; <string-name>
<surname>Hellenbroich</surname>
<given-names>Y</given-names>
</string-name> (<year>2004</year>). <article-title>Spinocerebellar ataxia type 5: clinical and molecular genetic features of a German kindred</article-title>. <source/>Neurology
<volume>62</volume>, <fpage>327</fpage>–<lpage>329</lpage>.<pub-id pub-id-type="pmid">14745083</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0009">
<mixed-citation id="tjp7081-cit-0009" publication-type="journal">
<string-name>
<surname>Cai</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>HX</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>XG</given-names>
</string-name>, <string-name>
<surname>Patrylo</surname>
<given-names>PR</given-names>
</string-name>, <string-name>
<surname>Rose</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Streeter</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hayes</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>KK</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>XX</given-names>
</string-name> &amp; <string-name>
<surname>Jeromin</surname>
<given-names>A</given-names>
</string-name> (<year>2012</year>). <article-title>Age‐related intraneuronal elevaton of αII‐spectrin breakdown product SBDP120 in rodent forebrain accelerates in 3 x Tg‐AD mice</article-title>. <source/>PLoS One
<volume>7</volume>, <fpage>e37599</fpage>.<pub-id pub-id-type="pmid">22723836</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0010">
<mixed-citation id="tjp7081-cit-0010" publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Brkanac</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Verlinde</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>XJ</given-names>
</string-name>, <string-name>
<surname>Bylenok</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Nochlin</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Matsushita</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lipe</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wolff</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fernandez</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cimino</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Bird</surname>
<given-names>TD</given-names>
</string-name> &amp; <string-name>
<surname>Raskind</surname>
<given-names>WH</given-names>
</string-name> (<year>2003</year>). <article-title>Missense mutations in the regulatory domain of PKCγ: a new mechanism for dominant nonepisodic cerebellar ataxia</article-title>. <source/>Am J Hum Genet
<volume>72</volume>, <fpage>839</fpage>–<lpage>849</lpage>.<pub-id pub-id-type="pmid">12644968</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0011">
<mixed-citation id="tjp7081-cit-0011" publication-type="journal">
<string-name>
<surname>Cho</surname>
<given-names>E</given-names>
</string-name> &amp; <string-name>
<surname>Fogel</surname>
<given-names>BL</given-names>
</string-name> (<year>2013</year>). <article-title>A family with spinocerebellar ataxia type 5 found to have a novel missense mutation within a SPTBN2 spectrin repeat</article-title>. <source/>Cerebellum
<volume>12</volume>, <fpage>162</fpage>–<lpage>164</lpage>.<pub-id pub-id-type="pmid">22843192</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0012">
<mixed-citation id="tjp7081-cit-0012" publication-type="journal">
<string-name>
<surname>Choquet</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>La Piana</surname>
<given-names>R</given-names>
</string-name> &amp; <string-name>
<surname>Brais</surname>
<given-names>B</given-names>
</string-name> (<year>2015</year>). <article-title>A novel frameshift mutation in FGF14 causes an autosomal dominant episodic ataxia</article-title>. <source/>Neurogenetics
<volume>16</volume>, <fpage>233</fpage>–<lpage>236</lpage>.<pub-id pub-id-type="pmid">25566820</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0013">
<mixed-citation id="tjp7081-cit-0013" publication-type="journal">
<string-name>
<surname>Chung</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Joo</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>MJ</given-names>
</string-name> &amp; <string-name>
<surname>Cha</surname>
<given-names>CI</given-names>
</string-name> (<year>2003</year>). <article-title>Age‐related changes in the distribution of Na<sub>v</sub>1.1 and Na<sub>v</sub>1.2 in rat cerebellum</article-title>. <source/>Neuroreport
<volume>14</volume>, <fpage>841</fpage>–<lpage>845</lpage>.<pub-id pub-id-type="pmid">12858044</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0014">
<mixed-citation id="tjp7081-cit-0014" publication-type="journal">
<string-name>
<surname>Clarkson</surname>
<given-names>YL</given-names>
</string-name>, <string-name>
<surname>Gillespie</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Perkins</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Lyndon</surname>
<given-names>AR</given-names>
</string-name> &amp; <string-name>
<surname>Jackson</surname>
<given-names>M</given-names>
</string-name> (<year>2010</year>). <article-title>β‐III spectrin mutation L253P associated with spinocerebellar ataxia type 5 interferes with binding to Arp1 and protein trafficking from the Golgi</article-title>. <source/>Hum Mol Genet
<volume>19</volume>, <fpage>3634</fpage>–<lpage>3641</lpage>.<pub-id pub-id-type="pmid">20603325</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0015">
<mixed-citation id="tjp7081-cit-0015" publication-type="journal">
<string-name>
<surname>Clarkson</surname>
<given-names>YL</given-names>
</string-name>, <string-name>
<surname>Perkins</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Cairncross</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Lyndon</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Skehel</surname>
<given-names>PA</given-names>
</string-name> &amp; <string-name>
<surname>Jackson</surname>
<given-names>M</given-names>
</string-name> (<year>2014</year>). <article-title>β‐III spectrin underpins ankyrin R function in Purkinje cell dendritic trees: protein complex critcal for sodium channel activity is impaired by SCA5‐associated mutations</article-title>. <source/>Hum Mol Genet
<volume>23</volume>, <fpage>3875</fpage>–<lpage>3882</lpage>.<pub-id pub-id-type="pmid">24603075</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0016">
<mixed-citation id="tjp7081-cit-0016" publication-type="journal">
<string-name>
<surname>Coebergh</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Fransen van de Putte</surname>
<given-names>DE</given-names>
</string-name>, <string-name>
<surname>Snoeck</surname>
<given-names>IN</given-names>
</string-name>, <string-name>
<surname>Ruivenkamp</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>van Haeringen</surname>
<given-names>A</given-names>
</string-name> &amp; <string-name>
<surname>Smit</surname>
<given-names>LM</given-names>
</string-name> (<year>2014</year>). <article-title>A new variable phenotype in spinocerebellar ataxia 27 (SCA 27) caused by a deletion in the FGF14 gene</article-title>. <source/>Eur J Paediatr Neurol
<volume>18</volume>, <fpage>413</fpage>–<lpage>415</lpage>.<pub-id pub-id-type="pmid">24252256</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0017">
<mixed-citation id="tjp7081-cit-0017" publication-type="journal">
<string-name>
<surname>Courchesne</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Saitoh</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Townsend</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Yeung‐Courchesne</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Press</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Lincoln</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Haas</surname>
<given-names>RH</given-names>
</string-name> &amp; <string-name>
<surname>Schriebman</surname>
<given-names>L</given-names>
</string-name> (<year>1994</year>). <article-title>Cerebellar hypoplasia and hyperplasia in infantile autism</article-title>. <source/>Lancet
<volume>343</volume>, <fpage>63</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="pmid">7905084</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0018">
<mixed-citation id="tjp7081-cit-0018" publication-type="journal">
<string-name>
<surname>Custer</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Garden</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Gill</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Rueb</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Libby</surname>
<given-names>RT</given-names>
</string-name>, <string-name>
<surname>Schultz</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Guyenet</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Deller</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Westrum</surname>
<given-names>LE</given-names>
</string-name>, <string-name>
<surname>Sopher</surname>
<given-names>BL</given-names>
</string-name> &amp; <string-name>
<surname>La Spada</surname>
<given-names>AR</given-names>
</string-name> (<year>2006</year>). <article-title>Bergmann glia expression of polyglutamine‐expanded ataxin‐7 produces neurodegeneration by impairing glutamate transport</article-title>. <source/>Nat Neurosci
<volume>9</volume>, <fpage>1302</fpage>–<lpage>1311</lpage>.<pub-id pub-id-type="pmid">16936724</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0019">
<mixed-citation id="tjp7081-cit-0019" publication-type="journal">
<string-name>
<surname>Cvetanovic</surname>
<given-names>M</given-names>
</string-name> (<year>2015</year>). <article-title>Decreased expression of glutamate transporter GLAST in bergmann glia is associated with the loss of Purkinje neurons in the spinocerebellar ataxia type 1</article-title>. <source/>Cerebellum
<volume>14</volume>, <fpage>8</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="pmid">25255716</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0020">
<mixed-citation id="tjp7081-cit-0020" publication-type="journal">
<string-name>
<surname>Dalski</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Atici</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kreuz</surname>
<given-names>FR</given-names>
</string-name>, <string-name>
<surname>Hellenbroich</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Schwinger</surname>
<given-names>E</given-names>
</string-name> &amp; <string-name>
<surname>Zühlke</surname>
<given-names>C</given-names>
</string-name> (<year>2005</year>). <article-title>Mutation analysis in the fibroblast growth factor 14 gene: frameshift mutation and polymorphisms in patients with inherited ataxias</article-title>. <source/>Eur J Hum Genet
<volume>13</volume>, <fpage>118</fpage>–<lpage>120</lpage>.<pub-id pub-id-type="pmid">15470364</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0021">
<mixed-citation id="tjp7081-cit-0021" publication-type="journal">
<string-name>
<surname>David</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Abbas</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Stevanin</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Durr</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yvert</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Cancel</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Weber</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Imbert</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Saudou</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Antoniou</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Drabkin</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Gemmill</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Giunti</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Benomar</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wood</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Ruberg</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Agid</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Mandel</surname>
<given-names>JL</given-names>
</string-name> &amp; <string-name>
<surname>Brice</surname>
<given-names>A</given-names>
</string-name> (<year>1997</year>). <article-title>Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion</article-title>. <source/>Nat Genet
<volume>17</volume>, <fpage>65</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="pmid">9288099</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0022">
<mixed-citation id="tjp7081-cit-0022" publication-type="journal">
<string-name>
<surname>Dehnes</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chaudhry</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Ullensvang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Lehre</surname>
<given-names>KP</given-names>
</string-name>, <string-name>
<surname>Storm‐Mathisen</surname>
<given-names>J</given-names>
</string-name> &amp; <string-name>
<surname>Danbolt</surname>
<given-names>NC</given-names>
</string-name> (<year>1998</year>). <article-title>The glutamate transporter EAAT4 in rat cerebellar Purkinje cells: a glutamate‐gated chloride channel concentrated near the synapse in parts of the dendritic membrane facing astroglia</article-title>. <source/>J Neurosci
<volume>18</volume>, <fpage>3606</fpage>–<lpage>3619</lpage>.<pub-id pub-id-type="pmid">9570792</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0023">
<mixed-citation id="tjp7081-cit-0023" publication-type="journal">
<string-name>
<surname>de Vries</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Mamsa</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Stam</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Wan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Bakker</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Vanmolkot</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Haan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Terwindt</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Boon</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Howard</surname>
<given-names>BD</given-names>
</string-name>, <string-name>
<surname>Frants</surname>
<given-names>RR</given-names>
</string-name>, <string-name>
<surname>Baloh</surname>
<given-names>RW</given-names>
</string-name>, <string-name>
<surname>Ferrari</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Jen</surname>
<given-names>JC</given-names>
</string-name> &amp; <string-name>
<surname>van den Maagdenberg</surname>
<given-names>AM</given-names>
</string-name> (<year>2009</year>). <article-title>Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake</article-title>. <source/>Arch Neurol
<volume>66</volume>, <fpage>97</fpage>–<lpage>101</lpage>.<pub-id pub-id-type="pmid">19139306</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0024">
<mixed-citation id="tjp7081-cit-0024" publication-type="journal">
<string-name>
<surname>Di Bella</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Lazzaro</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Brusco</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Plumari</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Battaglia</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Pastore</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Finardi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cagnoli</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Tempia</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Frontali</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Veneziano</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Sacco</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Boda</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Brussino</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bonn</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Castellotti</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Baratta</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mariotti</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Gellera</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Fracasso</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Magri</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Langer</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Plevani</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Di Donato</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Muzi‐Falconi</surname>
<given-names>M</given-names>
</string-name> &amp; <string-name>
<surname>Taroni</surname>
<given-names>F</given-names>
</string-name> (<year>2010</year>). <article-title>Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28</article-title>. <source/>Nat Genet
<volume>42</volume>, <fpage>313</fpage>–<lpage>321</lpage>.<pub-id pub-id-type="pmid">20208537</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0025">
<mixed-citation id="tjp7081-cit-0025" publication-type="journal">
<string-name>
<surname>Dlugos</surname>
<given-names>CA</given-names>
</string-name> (<year>2005</year>). <article-title>Analyses of smooth endoplasmic reticulum of cerebellar parallel fibers in aging, ethanol‐fed rats</article-title>. <source/>Alcohol
<volume>35</volume>, <fpage>67</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="pmid">15922139</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0026">
<mixed-citation id="tjp7081-cit-0026" publication-type="journal">
<string-name>
<surname>Duarri</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Jezierska</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fokkens</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Meijer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Schelhaas</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>den Dunnen</surname>
<given-names>WF</given-names>
</string-name>, <string-name>
<surname>van Dijk</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Verschuuren‐Bemelmans</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hageman</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>van de Vlies</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Küsters</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>van de Warrenburg</surname>
<given-names>BP</given-names>
</string-name>, <string-name>
<surname>Kremer</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Wijmenga</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Sinke</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Swertz</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Kampinga</surname>
<given-names>HH</given-names>
</string-name>, <string-name>
<surname>Boddeke</surname>
<given-names>E</given-names>
</string-name> &amp; <string-name>
<surname>Verbeek</surname>
<given-names>DS</given-names>
</string-name> (<year>2012</year>). <article-title>Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19</article-title>. <source/>Ann Neurol
<volume>72</volume>, <fpage>870</fpage>–<lpage>880</lpage>.<pub-id pub-id-type="pmid">23280838</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0027">
<mixed-citation id="tjp7081-cit-0027" publication-type="journal">
<string-name>
<surname>Elsayed</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Heller</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Thoenes</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zaki</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Swan</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Elsobky</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Zühlke</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ebermann</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Nürnberg</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Nürnberg</surname>
<given-names>P</given-names>
</string-name> &amp; <string-name>
<surname>Bolz</surname>
<given-names>HJ</given-names>
</string-name> (<year>2014</year>). <article-title>Autosomal dominant SCA5 and autosomal recessive infantile SCA are allelic conditions resulting from SPTBN2 mutations</article-title>. <source/>Eur J Hum Genet
<volume>22</volume>, <fpage>286</fpage>–<lpage>288</lpage>.<pub-id pub-id-type="pmid">23838597</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0028">
<mixed-citation id="tjp7081-cit-0028" publication-type="journal">
<string-name>
<surname>Forman</surname>
<given-names>OP</given-names>
</string-name>, <string-name>
<surname>De Risio</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Stewart</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mellersh</surname>
<given-names>CS</given-names>
</string-name> &amp; <string-name>
<surname>Beltran</surname>
<given-names>E</given-names>
</string-name> (<year>2012</year>). <article-title>Genome‐wide mRNA sequencing of a single canine cerebellar cortical degeneration case leads to the identification of a disease associated SPTBN2 mutation</article-title>. <source/>BMC Genet
<volume>13</volume>, <fpage>55</fpage>.<pub-id pub-id-type="pmid">22781464</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0029">
<mixed-citation id="tjp7081-cit-0029" publication-type="journal">
<string-name>
<surname>Gao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Perkins</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Clarkson</surname>
<given-names>YL</given-names>
</string-name>, <string-name>
<surname>Tobia</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lyndon</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Jackson</surname>
<given-names>M</given-names>
</string-name> &amp; <string-name>
<surname>Rothstein</surname>
<given-names>JD</given-names>
</string-name> (<year>2011</year>). <article-title>β‐III spectrin is critical for development of Purkinje cell dendritic tree and spine morphogenesis</article-title>. <source/>J Neurosci
<volume>31</volume>, <fpage>16581</fpage>–<lpage>16590</lpage>.<pub-id pub-id-type="pmid">22090485</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0030">
<mixed-citation id="tjp7081-cit-0030" publication-type="journal">
<string-name>
<surname>Goetz</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Liem</surname>
<given-names>KF</given-names>
<suffix>Jr</suffix>
</string-name> &amp; <string-name>
<surname>Anderson</surname>
<given-names>KV</given-names>
</string-name> (<year>2012</year>). <article-title>The spinocerebellar ataxia‐associated gene Tau tubulin kinase 2 controls the initiation of ciliogenesis</article-title>. <source/>Cell
<volume>151</volume>, <fpage>847</fpage>–<lpage>858</lpage>.<pub-id pub-id-type="pmid">23141541</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0031">
<mixed-citation id="tjp7081-cit-0031" publication-type="journal">
<string-name>
<surname>Gulledge</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Kampa</surname>
<given-names>BM</given-names>
</string-name> &amp; <string-name>
<surname>Stuart</surname>
<given-names>GJ</given-names>
</string-name> (<year>2005</year>). <article-title>Synaptic integration in dendritic trees</article-title>. <source/>J Neurobiol
<volume>64</volume>, <fpage>75</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">15884003</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0032">
<mixed-citation id="tjp7081-cit-0032" publication-type="journal">
<string-name>
<surname>Guo</surname>
<given-names>YC</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Liao</surname>
<given-names>YC</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>YC</given-names>
</string-name> &amp; <string-name>
<surname>Soong</surname>
<given-names>BW</given-names>
</string-name> (<year>2014</year>). <article-title>Spinocerebellar ataxia 35: novel mutations in TGM6 with clinical and genetic characterization</article-title>. <source/>Neurology
<volume>83</volume>, <fpage>1554</fpage>–<lpage>1561</lpage>.<pub-id pub-id-type="pmid">25253745</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0033">
<mixed-citation id="tjp7081-cit-0033" publication-type="journal">
<string-name>
<surname>Hansen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Meera</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Otis</surname>
<given-names>TS</given-names>
</string-name> &amp; <string-name>
<surname>Pulst</surname>
<given-names>SM</given-names>
</string-name> (<year>2013</year>). <article-title>Changes in Purkinje cell firing and gene expression precede behavioural pathology in a mouse model of SCA2</article-title>. <source/>Hum Mol Genet
<volume>22</volume>, <fpage>271</fpage>–<lpage>283</lpage>.<pub-id pub-id-type="pmid">23087021</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0034">
<mixed-citation id="tjp7081-cit-0034" publication-type="journal">
<string-name>
<surname>Häusser</surname>
<given-names>M</given-names>
</string-name> &amp; <string-name>
<surname>Clark</surname>
<given-names>BA</given-names>
</string-name> (<year>1997</year>). <article-title>Tonic synaptic inhibition modulates neuronal output pattern and spatiotemporal synaptic integration</article-title>. <source/>Neuron
<volume>19</volume>, <fpage>665</fpage>–<lpage>678</lpage>.<pub-id pub-id-type="pmid">9331356</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0035">
<mixed-citation id="tjp7081-cit-0035" publication-type="journal">
<string-name>
<surname>Häusser</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Spruston</surname>
<given-names>N</given-names>
</string-name> &amp; <string-name>
<surname>Stuart</surname>
<given-names>GJ</given-names>
</string-name> (<year>2000</year>). <article-title>Diversity and dynamics of dendritic signaling</article-title>. <source/>Science
<volume>290</volume>, <fpage>739</fpage>–<lpage>744</lpage>.<pub-id pub-id-type="pmid">11052929</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0036">
<mixed-citation id="tjp7081-cit-0036" publication-type="journal">
<string-name>
<surname>Hekman</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>GY</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>CD</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Du</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Gervin</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Undlien</surname>
<given-names>DE</given-names>
</string-name>, <string-name>
<surname>Peterson</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Stevanin</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Clark</surname>
<given-names>HB</given-names>
</string-name>, <string-name>
<surname>Pulst</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Bird</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>White</surname>
<given-names>KP</given-names>
</string-name> &amp; <string-name>
<surname>Gomez</surname>
<given-names>CM</given-names>
</string-name> (<year>2012</year>). <article-title>A conserved eEF2 coding variant in SCA26 leads to loss of translational fidelity and increased susceptibility to proteostatic insult</article-title>. <source/>Hum Mol Genet
<volume>21</volume>, <fpage>5472</fpage>–<lpage>5483</lpage>.<pub-id pub-id-type="pmid">23001565</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0037">
<mixed-citation id="tjp7081-cit-0037" publication-type="journal">
<string-name>
<surname>Holleran</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Ligon</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Tokito</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Stakewich</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Morrow</surname>
<given-names>JS</given-names>
</string-name> &amp; <string-name>
<surname>Holzbaur</surname>
<given-names>LF</given-names>
</string-name> (<year>2001</year>). <article-title>βIII spectrin binds to the Arp1 subunit of dynactin</article-title>. <source/>J Biol Chem
<volume>276</volume>, <fpage>36598</fpage>–<lpage>36605</lpage>.<pub-id pub-id-type="pmid">11461920</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0038">
<mixed-citation id="tjp7081-cit-0038" publication-type="journal">
<string-name>
<surname>Holmes</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>O'Hearn</surname>
<given-names>EE</given-names>
</string-name>, <string-name>
<surname>McInnis</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Gorelick‐Feldman</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Kleiderlein</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Callahan</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Kwak</surname>
<given-names>NG</given-names>
</string-name>, <string-name>
<surname>Ingersoll‐Ashworth</surname>
<given-names>RG</given-names>
</string-name>, <string-name>
<surname>Sherr</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sumner</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Sharp</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Ananth</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Seltzer</surname>
<given-names>WK</given-names>
</string-name>, <string-name>
<surname>Boss</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Vieria‐Saecker</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Epplen</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Riess</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Ross</surname>
<given-names>CA</given-names>
</string-name> &amp; <string-name>
<surname>Margolis</surname>
<given-names>RL</given-names>
</string-name> (<year>1999</year>). <article-title>Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12</article-title>. <source/>Nat Genet
<volume>23</volume>, <fpage>391</fpage>–<lpage>392</lpage>.<pub-id pub-id-type="pmid">10581021</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0039">
<mixed-citation id="tjp7081-cit-0039" publication-type="journal">
<string-name>
<surname>Houlden</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gardner‐Thorpe</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lashley</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hernandez</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Worth</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Singleton</surname>
<given-names>AB</given-names>
</string-name>, <string-name>
<surname>Hilton</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Holton</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Revesz</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Davis</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Giunti</surname>
<given-names>P</given-names>
</string-name> &amp; <string-name>
<surname>Wood</surname>
<given-names>NW</given-names>
</string-name> (<year>2007</year>). <article-title>Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11</article-title>. <source/>Nat Genet
<volume>39</volume>, <fpage>1434</fpage>–<lpage>1436</lpage>.<pub-id pub-id-type="pmid">18037885</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0040">
<mixed-citation id="tjp7081-cit-0040" publication-type="journal">
<string-name>
<surname>Hourez</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Servais</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Orduz</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Gall</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Millard</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>de Kerchove d'Exaerde</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cheron</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Orr</surname>
<given-names>HT</given-names>
</string-name>, <string-name>
<surname>Pandolfo</surname>
<given-names>M</given-names>
</string-name> &amp; <string-name>
<surname>Schiffmann</surname>
<given-names>SN</given-names>
</string-name> (<year>2011</year>). <article-title>Aminopyridines correct early dysfunction and dealy neurodegeneration in a mouse model of spinocerebellar ataxia type 1</article-title>. <source/>J Neurosci
<volume>31</volume>, <fpage>11795</fpage>–<lpage>11807</lpage>.<pub-id pub-id-type="pmid">21849540</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0041">
<mixed-citation id="tjp7081-cit-0041" publication-type="journal">
<string-name>
<surname>Huang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Chardon</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Carter</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Friend</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Dudding</surname>
<given-names>TE</given-names>
</string-name>, <string-name>
<surname>Schwartzentruber</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zou</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Schofield</surname>
<given-names>PW</given-names>
</string-name>, <string-name>
<surname>Douglas</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bulman</surname>
<given-names>DE</given-names>
</string-name> &amp; <string-name>
<surname>Boycott</surname>
<given-names>KM</given-names>
</string-name> (<year>2012</year>). <article-title>Missense mutation in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxia</article-title>. <source/>Orphanet J Rare Dis
<volume>7</volume>, <fpage>67</fpage>.<pub-id pub-id-type="pmid">22986007</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0042">
<mixed-citation id="tjp7081-cit-0042" publication-type="journal">
<string-name>
<surname>Hurlock</surname>
<given-names>EC</given-names>
</string-name>, <string-name>
<surname>McMahon</surname>
<given-names>A</given-names>
</string-name> &amp; <string-name>
<surname>Joho</surname>
<given-names>RH</given-names>
</string-name> (<year>2008</year>). <article-title>Purkinje‐cell‐restricted restoration of Kv3.3 function restores complex spikes and rescues motor coordination in Kcnc3 mutants</article-title>. <source/>J Neurosci
<volume>28</volume>, <fpage>4640</fpage>–<lpage>4648</lpage>.<pub-id pub-id-type="pmid">18448641</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0043">
<mixed-citation id="tjp7081-cit-0043" publication-type="journal">
<string-name>
<surname>Hwang</surname>
<given-names>IK</given-names>
</string-name>, <string-name>
<surname>Ahn</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Yoo</surname>
<given-names>DY</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Yoo</surname>
<given-names>KY</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Moon</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Shin</surname>
<given-names>HC</given-names>
</string-name> &amp; <string-name>
<surname>Won</surname>
<given-names>MH</given-names>
</string-name> (<year>2012</year>). <article-title>Increased immunoreactivities of cleaved αII‐spectrin and cleaved caspase‐3 in the aged dog spinal cord</article-title>. <source/>Neurochem Res
<volume>37</volume>, <fpage>480</fpage>–<lpage>486</lpage>.<pub-id pub-id-type="pmid">22037840</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0044">
<mixed-citation id="tjp7081-cit-0044" publication-type="journal">
<string-name>
<surname>Ikeda</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Dick</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Weatherspoon</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Gincel</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Armbrust</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Dalton</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Stevanin</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Dürr</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Zühlke</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Bürk</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Clark</surname>
<given-names>HB</given-names>
</string-name>, <string-name>
<surname>Brice</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rothstein</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Schut</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Day</surname>
<given-names>JW</given-names>
</string-name> &amp; <string-name>
<surname>Ranum</surname>
<given-names>LP</given-names>
</string-name> (<year>2006</year>). <article-title>Spectrin mutations cause spinocerebellar ataxia type 5</article-title>. <source/>Nat Genet
<volume>38</volume>, <fpage>184</fpage>–<lpage>190</lpage>.<pub-id pub-id-type="pmid">16429157</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0045">
<mixed-citation id="tjp7081-cit-0045" publication-type="journal">
<string-name>
<surname>Imbert</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Saudou</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Yvert</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Devys</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Trottier</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Gamier</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Weber</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mandel</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Cancel</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Abbas</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Dürr</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Didierjean</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Stevanin</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Agid</surname>
<given-names>Y</given-names>
</string-name> &amp; <string-name>
<surname>Brice</surname>
<given-names>A</given-names>
</string-name> (<year>1996</year>). <article-title>Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats</article-title>. <source/>Nat Genet
<volume>14</volume>, <fpage>285</fpage>–<lpage>291</lpage>.<pub-id pub-id-type="pmid">8896557</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0046">
<mixed-citation id="tjp7081-cit-0046" publication-type="journal">
<string-name>
<surname>Irie</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Matsuzaki</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sekino</surname>
<given-names>Y</given-names>
</string-name> &amp; <string-name>
<surname>Hirai</surname>
<given-names>H</given-names>
</string-name> (<year>2014</year>). <article-title>Kv3.3 channels harbouring a mutation of spinocerebellar ataxia type 13 alter excitability and induce cell death in cultured cerebellar Purkinje cells</article-title>. <source/>J Physiol
<volume>592</volume>, <fpage>229</fpage>–<lpage>247</lpage>.<pub-id pub-id-type="pmid">24218544</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0047">
<mixed-citation id="tjp7081-cit-0047" publication-type="journal">
<string-name>
<surname>Iwaki</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kawano</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Miura</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shibata</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Matsuse</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Furuya</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ohyagi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Taniwaki</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kira</surname>
<given-names>J</given-names>
</string-name> &amp; <string-name>
<surname>Fukumaki</surname>
<given-names>Y</given-names>
</string-name> (<year>2008</year>). <article-title>Heterozygous deletion of ITPR1, but not SUMF1, in spinocerebellar ataxia type 16</article-title>. <source/>J Med Genet
<volume>45</volume>, <fpage>32</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="pmid">17932120</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0048">
<mixed-citation id="tjp7081-cit-0048" publication-type="journal">
<string-name>
<surname>Jackson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>MY</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Dykes‐Hoberg</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>CI</given-names>
</string-name>, <string-name>
<surname>Bowers</surname>
<given-names>WJ</given-names>
</string-name>, <string-name>
<surname>Federoff</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Sternweis</surname>
<given-names>PC</given-names>
</string-name> &amp; <string-name>
<surname>Rothstein</surname>
<given-names>JD</given-names>
</string-name> (<year>2001</year>). <article-title>Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins</article-title>. <source/>Nature
<volume>410</volume>, <fpage>89</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="pmid">11242047</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0049">
<mixed-citation id="tjp7081-cit-0049" publication-type="journal">
<string-name>
<surname>Jacob</surname>
<given-names>FD</given-names>
</string-name>, <string-name>
<surname>Ho</surname>
<given-names>ES</given-names>
</string-name>, <string-name>
<surname>Martinez‐Ojeda</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Darras</surname>
<given-names>BT</given-names>
</string-name> &amp; <string-name>
<surname>Khwaja</surname>
<given-names>OS</given-names>
</string-name> (<year>2012</year>). <article-title>Case of infantile onset spinocerebellar ataxia type 5</article-title>. <source/>J Child Neurol
<volume>28</volume>, <fpage>1292</fpage>–<lpage>1295</lpage>.<pub-id pub-id-type="pmid">22914369</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0050">
<mixed-citation id="tjp7081-cit-0050" publication-type="journal">
<string-name>
<surname>Jen</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Wan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Palos</surname>
<given-names>TP</given-names>
</string-name>, <string-name>
<surname>Howard</surname>
<given-names>BD</given-names>
</string-name> &amp; <string-name>
<surname>Baloh</surname>
<given-names>RW</given-names>
</string-name> (<year>2005</year>). <article-title>Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures</article-title>. <source/>Neurology
<volume>65</volume>, <fpage>529</fpage>–<lpage>534</lpage>.<pub-id pub-id-type="pmid">16116111</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0051">
<mixed-citation id="tjp7081-cit-0051" publication-type="journal">
<string-name>
<surname>Jezierska</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Stevanin</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Watanabe</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Fokkens</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Zagnoli</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Kok</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Goas</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Bertrand</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Robin</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Brice</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bakalkin</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Durr</surname>
<given-names>A</given-names>
</string-name> &amp; <string-name>
<surname>Verbeek</surname>
<given-names>DS</given-names>
</string-name> (<year>2013</year>). <article-title>Identification and characterization of novel PDYN mutations in dominant cerebellar ataxia cases</article-title>. <source/>J Neurol
<volume>260</volume>, <fpage>1807</fpage>–<lpage>1812</lpage>.<pub-id pub-id-type="pmid">23471613</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0052">
<mixed-citation id="tjp7081-cit-0052" publication-type="journal">
<string-name>
<surname>Kalume</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>FH</given-names>
</string-name>, <string-name>
<surname>Westenbroek</surname>
<given-names>RE</given-names>
</string-name>, <string-name>
<surname>Scheuer</surname>
<given-names>T</given-names>
</string-name> &amp; <string-name>
<surname>Catterall</surname>
<given-names>WA</given-names>
</string-name> (<year>2007</year>). <article-title>Reduced sodium current in Purkinje neurons from Nav1.1 mutant mice: Implications for ataxia in severe myoclonic epilepsy in infancy</article-title>. <source/>J Neurosci
<volume>27</volume>, <fpage>11065</fpage>–<lpage>11074</lpage>.<pub-id pub-id-type="pmid">17928448</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0053">
<mixed-citation id="tjp7081-cit-0053" publication-type="journal">
<string-name>
<surname>Karki</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tokito</surname>
<given-names>MK</given-names>
</string-name> &amp; <string-name>
<surname>Holzbaur</surname>
<given-names>EL</given-names>
</string-name> (<year>2000</year>). <article-title>A dynactin subunit with a highly conserved cystein‐rich motif interacts directly with Arp1</article-title>. <source/>J Biol Chem
<volume>275</volume>, <fpage>4834</fpage>–<lpage>4839</lpage>.<pub-id pub-id-type="pmid">10671518</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0054">
<mixed-citation id="tjp7081-cit-0054" publication-type="journal">
<string-name>
<surname>Kawaguchi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Okamoto</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Taniwaki</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Aizawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Inoue</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Katayama</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kawakami</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Nakamura</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Nishimura</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Akiguchi</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Kimura</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Narumiya</surname>
<given-names>S</given-names>
</string-name> &amp; <string-name>
<surname>Kakizuka</surname>
<given-names>A</given-names>
</string-name> (<year>1994</year>). <article-title>CAG expansions in a novel gene for Machado‐Joseph disease at chromosome 14q32.1</article-title>. <source/>Nat Genet
<volume>8</volume>, <fpage>221</fpage>–<lpage>227</lpage>.<pub-id pub-id-type="pmid">7874163</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0055">
<mixed-citation id="tjp7081-cit-0055" publication-type="journal">
<string-name>
<surname>Khaliq</surname>
<given-names>ZM</given-names>
</string-name>, <string-name>
<surname>Gouwens</surname>
<given-names>NW</given-names>
</string-name> &amp; <string-name>
<surname>Raman</surname>
<given-names>IM</given-names>
</string-name> (<year>2003</year>). <article-title>The contribution of resurgent sodium current to high frequency firing in Purkinje neurons: an experimental and modelling study</article-title>. <source/>J Neurosci
<volume>23</volume>, <fpage>4899</fpage>–<lpage>4912</lpage>.<pub-id pub-id-type="pmid">12832512</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0056">
<mixed-citation id="tjp7081-cit-0056" publication-type="journal">
<string-name>
<surname>Kobayashi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Abe</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Matsuura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ikeda</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hitomi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Akechi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Habu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Okuda</surname>
<given-names>H</given-names>
</string-name> &amp; <string-name>
<surname>Kolzumi</surname>
<given-names>A</given-names>
</string-name> (<year>2011</year>). <article-title>Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement</article-title>. <source/>Am J Hum Genet
<volume>89</volume>, <fpage>121</fpage>–<lpage>130</lpage>.<pub-id pub-id-type="pmid">21683323</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0057">
<mixed-citation id="tjp7081-cit-0057" publication-type="journal">
<string-name>
<surname>Konarski</surname>
<given-names>JZ</given-names>
</string-name>, <string-name>
<surname>McIntyre</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Grupp</surname>
<given-names>LA</given-names>
</string-name> &amp; <string-name>
<surname>Kennedy</surname>
<given-names>SH</given-names>
</string-name> (<year>2005</year>). <article-title>Is the cerebellum relevant in the circuitry of neuropsychiatric disorders?</article-title>
<source/>J Psychiatry Neurosci
<volume>30</volume>, <fpage>178</fpage>–<lpage>186</lpage>.<pub-id pub-id-type="pmid">15944742</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0058">
<mixed-citation id="tjp7081-cit-0058" publication-type="journal">
<string-name>
<surname>Konno</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Shuvaev</surname>
<given-names>AN</given-names>
</string-name>, <string-name>
<surname>Miyake</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Miyake</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Iizuka</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Matsuura</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Huda</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Nakamura</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yanagi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shimada</surname>
<given-names>T</given-names>
</string-name> &amp; <string-name>
<surname>Hirai</surname>
<given-names>H</given-names>
</string-name> (<year>2014</year>). <article-title>Mutant ataxin‐3 with an abnormally expanded polyglutamine chain disrupts dendritic development and metabotropic glutamate receptor signaling in mouse cerebellar Purkinje cells</article-title>. <source/>Cerebellum
<volume>13</volume>, <fpage>29</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">23955261</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0059">
<mixed-citation id="tjp7081-cit-0059" publication-type="journal">
<string-name>
<surname>Koob</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Moseley</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Schut</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Benzow</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Bird</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>Day</surname>
<given-names>JW</given-names>
</string-name> &amp; <string-name>
<surname>Ranum</surname>
<given-names>LP</given-names>
</string-name> (<year>1999</year>). <article-title>An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8)</article-title>. <source/>Nat Genet
<volume>21</volume>, <fpage>379</fpage>–<lpage>384</lpage>.<pub-id pub-id-type="pmid">10192387</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0060">
<mixed-citation id="tjp7081-cit-0060" publication-type="journal">
<string-name>
<surname>Laezza</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Gerber</surname>
<given-names>BR</given-names>
</string-name>, <string-name>
<surname>Lou</surname>
<given-names>J‐Y</given-names>
</string-name>, <string-name>
<surname>Kozel</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Hartman</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Craig</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Ornitz</surname>
<given-names>DM</given-names>
</string-name> &amp; <string-name>
<surname>Nerbonne</surname>
<given-names>JM</given-names>
</string-name> (<year>2007</year>). <article-title>The FGF14<sup>F145S</sup> mutation disrupts the interaction of FGF14 with voltage‐gated Na<sup>+</sup> channels and impairs neuronal excitability</article-title>. <source/>J Neurosci
<volume>27</volume>, <fpage>12033</fpage>–<lpage>12044</lpage>.<pub-id pub-id-type="pmid">17978045</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0061">
<mixed-citation id="tjp7081-cit-0061" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>YC</given-names>
</string-name>, <string-name>
<surname>Durr</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Majczenko</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>YC</given-names>
</string-name>, <string-name>
<surname>Lien</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Ichikawa</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Goto</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Monin</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>JZ</given-names>
</string-name>, <string-name>
<surname>Chung</surname>
<given-names>MY</given-names>
</string-name>, <string-name>
<surname>Mundwiller</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Shakkottai</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>TT</given-names>
</string-name>, <string-name>
<surname>Tesson</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>YC</given-names>
</string-name>, <string-name>
<surname>Brice</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tsuji</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Burmeister</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Stevanin</surname>
<given-names>G</given-names>
</string-name> &amp; <string-name>
<surname>Soong</surname>
<given-names>BW</given-names>
</string-name> (<year>2012</year>). <article-title>Mutations in KCND3 cause spinocerebellar ataxia type 22</article-title>. <source/>Ann Neurol
<volume>72</volume>, <fpage>859</fpage>–<lpage>869</lpage>.<pub-id pub-id-type="pmid">23280837</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0062">
<mixed-citation id="tjp7081-cit-0062" publication-type="journal">
<string-name>
<surname>Lin</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Antalffy</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Orr</surname>
<given-names>HT</given-names>
</string-name> &amp; <string-name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</string-name> (<year>2000</year>). <article-title>Polyglutamine expansion down‐regulates specific neuronal genes before pathologic changes in SCA1</article-title>. <source/>Nat Neurosci
<volume>3</volume>, <fpage>157</fpage>–<lpage>163</lpage>.<pub-id pub-id-type="pmid">10649571</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0063">
<mixed-citation id="tjp7081-cit-0063" publication-type="journal">
<string-name>
<surname>Lise</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Clarkson</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Perkins</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kwasniewska</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sadighi Akha</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Schnekenberg</surname>
<given-names>RP</given-names>
</string-name>, <string-name>
<surname>Suminaite</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hope</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Baker</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Gregory</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Green</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Allan</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lambie</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jayawant</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Quaghebeur</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Cader</surname>
<given-names>MZ</given-names>
</string-name>, <string-name>
<surname>Hughes</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Armstrong</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Kanapin</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rimmer</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lunter</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Mathieson</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Cazier</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Buck</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Taylor</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Bentley</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>McVean</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Donnelly</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Knight</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Jackson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ragoussis</surname>
<given-names>J</given-names>
</string-name> &amp; <string-name>
<surname>Nemeth</surname>
<given-names>AH</given-names>
</string-name> (<year>2012</year>). <article-title>Recessive mutations in SPTBN2 implicate β‐III spectrin in both cognitive and motor development</article-title>. <source/>PLoS Genet
<volume>8</volume>, <fpage>e1003074</fpage>.<pub-id pub-id-type="pmid">23236289</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0064">
<mixed-citation id="tjp7081-cit-0064" publication-type="journal">
<string-name>
<surname>Lorenzo</surname>
<given-names>DN</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Mische</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Armbrust</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Ranum</surname>
<given-names>LP</given-names>
</string-name> &amp; <string-name>
<surname>Hays</surname>
<given-names>TS</given-names>
</string-name> (<year>2010</year>). <article-title>Spectrin mutations that cause spinocerebellar ataxia type 5 impair axonal transport and induce neurodegeneration in <italic>Drosophila</italic>
</article-title>. <source/>J Cell Biol
<volume>189</volume>, <fpage>143</fpage>–<lpage>158</lpage>.<pub-id pub-id-type="pmid">20368622</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0065">
<mixed-citation id="tjp7081-cit-0065" publication-type="journal">
<string-name>
<surname>Lou</surname>
<given-names>J‐Y</given-names>
</string-name>, <string-name>
<surname>Laezza</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Gerber</surname>
<given-names>BR</given-names>
</string-name>, <string-name>
<surname>Xiao</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yamada</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Hartmann</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Craig</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Nerbonne</surname>
<given-names>JM</given-names>
</string-name> &amp; <string-name>
<surname>Ornitz</surname>
<given-names>DM</given-names>
</string-name> (<year>2005</year>). <article-title>Fibroblast growth factor 14 is an intracellular modulator of voltage‐gated sodium channels</article-title>. <source/>J Physiol
<volume>569</volume>, <fpage>179</fpage>–<lpage>193</lpage>.<pub-id pub-id-type="pmid">16166153</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0066">
<mixed-citation id="tjp7081-cit-0066" publication-type="journal">
<string-name>
<surname>Maltecca</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Baseggio</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Consolato</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Mazza</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Podini</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Young</surname>
<given-names>SM</given-names>
<suffix>Jr</suffix>
</string-name>, <string-name>
<surname>Drago</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Bahr</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Puliti</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Codazzi</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Quattrini</surname>
<given-names>A</given-names>
</string-name> &amp; <string-name>
<surname>Casari</surname>
<given-names>G</given-names>
</string-name> (<year>2015</year>). <article-title>Purkinje neuron Ca<sup>2+</sup> influx reduction rescues ataxia in SCA28 model</article-title>. <source/>J Clin Invest
<volume>125</volume>, <fpage>263</fpage>–<lpage>274</lpage>.<pub-id pub-id-type="pmid">25485680</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0067">
<mixed-citation id="tjp7081-cit-0067" publication-type="journal">
<string-name>
<surname>Maltecca</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Magnoni</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Cerri</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Cox</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Quattrini</surname>
<given-names>A</given-names>
</string-name> &amp; <string-name>
<surname>Casari</surname>
<given-names>G</given-names>
</string-name> (<year>2009</year>). <article-title>Haploinsufficiency of AFG3L2, the gene responsible for spinocerebellar ataxia type 28, causes mitochondria‐mediated Purkinje cell degeneration</article-title>. <source/>J Neurosci
<volume>29</volume>, <fpage>9244</fpage>–<lpage>9254</lpage>.<pub-id pub-id-type="pmid">19625515</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0068">
<mixed-citation id="tjp7081-cit-0068" publication-type="journal">
<string-name>
<surname>Mansouri</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Henne</surname>
<given-names>WM</given-names>
</string-name>, <string-name>
<surname>Oomman</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Bliss</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Attridge</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Finckbone</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Zeitouni</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hoffman</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Bahr</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Strahlendorf</surname>
<given-names>HK</given-names>
</string-name> &amp; <string-name>
<surname>Strahlendorf</surname>
<given-names>JC</given-names>
</string-name> (<year>2007</year>). <article-title>Involvement of calpain in AMPA‐induced toxicity to rat cerebellar Purkinje neurons</article-title>. <source/>Eur J Pharmacol
<volume>557</volume>, <fpage>106</fpage>–<lpage>114</lpage>.<pub-id pub-id-type="pmid">17188264</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0069">
<mixed-citation id="tjp7081-cit-0069" publication-type="journal">
<string-name>
<surname>Manto</surname>
<given-names>M</given-names>
</string-name> (<year>2008</year>). <article-title>The cerebellum, cerebellar disorders, and cerebellar research – two centuries of discoveries</article-title>. <source/>Cerebellum
<volume>7</volume>, <fpage>505</fpage>–<lpage>516</lpage>.<pub-id pub-id-type="pmid">18855093</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0070">
<mixed-citation id="tjp7081-cit-0070" publication-type="journal">
<string-name>
<surname>Matsuoka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name> &amp; <string-name>
<surname>Bennett</surname>
<given-names>V</given-names>
</string-name> (<year>1998</year>). <article-title>Adducin is an in vivo substrate for protein kinase C: Phosphorylation in the MARCKS‐related domain inhibits activity in promoting spectrin‐actin complexes and occurs in many cells, including dendritic spines of neurons</article-title>. <source/>J Cell Biol
<volume>142</volume>, <fpage>485</fpage>–<lpage>497</lpage>.<pub-id pub-id-type="pmid">9679146</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0071">
<mixed-citation id="tjp7081-cit-0071" publication-type="journal">
<string-name>
<surname>Matsuura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yamagata</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Burgess</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Rasmussen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Grewal</surname>
<given-names>RP</given-names>
</string-name>, <string-name>
<surname>Watase</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Khajavi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>McCall</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Davis</surname>
<given-names>CF</given-names>
</string-name>, <string-name>
<surname>Zu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Achari</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pulst</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Alonso</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Noebels</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Nelson</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</string-name> &amp; <string-name>
<surname>Ashizawa</surname>
<given-names>T</given-names>
</string-name> (<year>2000</year>). <article-title>Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10</article-title>. <source/>Nat Genet
<volume>26</volume>, <fpage>191</fpage>–<lpage>194</lpage>.<pub-id pub-id-type="pmid">11017075</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0072">
<mixed-citation id="tjp7081-cit-0072" publication-type="journal">
<string-name>
<surname>Mavroudis</surname>
<given-names>IA</given-names>
</string-name>, <string-name>
<surname>Manani</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Petrides</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Petsoglou</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Njau</surname>
<given-names>SD</given-names>
</string-name>, <string-name>
<surname>Costa</surname>
<given-names>VG</given-names>
</string-name> &amp; <string-name>
<surname>Baloyannis</surname>
<given-names>SJ</given-names>
</string-name> (<year>2013</year>). <article-title>Dendritic and spinal pathology of the Purkinje cells from the human cerebellar vermis in Alzheimer's disease</article-title>. <source/>Psychiatr Danub
<volume>25</volume>, <fpage>221</fpage>–<lpage>226</lpage>.<pub-id pub-id-type="pmid">24048388</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0073">
<mixed-citation id="tjp7081-cit-0073" publication-type="journal">
<string-name>
<surname>Miyazaki</surname>
<given-names>T</given-names>
</string-name> &amp; <string-name>
<surname>Watanabe</surname>
<given-names>M</given-names>
</string-name> (<year>2011</year>). <article-title>Development of an anatomical technique for visualizing the mode of climbing fiber innervation in Purkinje cells and its application to mutant mice lacking GluRδ2 and Ca<sub>v</sub>2.1</article-title>. <source/>Anat Sci Int
<volume>86</volume>, <fpage>10</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="pmid">21153457</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0074">
<mixed-citation id="tjp7081-cit-0074" publication-type="journal">
<string-name>
<surname>Musova</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Kaiserova</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kriegova</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Fillerova</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Vasovcak</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Santava</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mensikova</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Zumrova</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Krepelova</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sedlacek</surname>
<given-names>Z</given-names>
</string-name> &amp; <string-name>
<surname>Kanovsky</surname>
<given-names>P</given-names>
</string-name> (<year>2014</year>). <article-title>A novel frameshift mutation in the AFG3L2 gene in a patient with spinocerebellar ataxia</article-title>. <source/>Cerebellum
<volume>13</volume>, <fpage>331</fpage>–<lpage>337</lpage>.<pub-id pub-id-type="pmid">24272953</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0075">
<mixed-citation id="tjp7081-cit-0075" publication-type="journal">
<string-name>
<surname>Nakamura</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Jeong</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Uchihara</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Anno</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nagashima</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nagashima</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ikeda</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tsuji</surname>
<given-names>S</given-names>
</string-name> &amp; <string-name>
<surname>Kanazawa</surname>
<given-names>I</given-names>
</string-name> (<year>2001</year>). <article-title>SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA‐binding protein</article-title>. <source/>Hum Mol Genet
<volume>10</volume>, <fpage>1441</fpage>–<lpage>1448</lpage>.<pub-id pub-id-type="pmid">11448935</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0076">
<mixed-citation id="tjp7081-cit-0076" publication-type="journal">
<string-name>
<surname>Napper</surname>
<given-names>RMA</given-names>
</string-name> &amp; <string-name>
<surname>Harvey</surname>
<given-names>RJ</given-names>
</string-name> (<year>1988</year>). <article-title>Number of parallel fiber synapses on an individual Purkinje cell in the cerebellum of the rat</article-title>. <source/>J Comp Neurol
<volume>274</volume>, <fpage>168</fpage>–<lpage>177</lpage>.<pub-id pub-id-type="pmid">3209740</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0077">
<mixed-citation id="tjp7081-cit-0077" publication-type="journal">
<string-name>
<surname>Orr</surname>
<given-names>HT</given-names>
</string-name>, <string-name>
<surname>Chung</surname>
<given-names>MY</given-names>
</string-name>, <string-name>
<surname>Banfi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kwiatkowski</surname>
<given-names>TJ</given-names>
<suffix>Jr</suffix>
</string-name>, <string-name>
<surname>Servadio</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Beaudet</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>McCall</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Duvick</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Ranum</surname>
<given-names>LP</given-names>
</string-name> &amp; <string-name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</string-name> (<year>1993</year>). <article-title>Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1</article-title>. <source/>Nat Genet
<volume>4</volume>, <fpage>221</fpage>–<lpage>226</lpage>.<pub-id pub-id-type="pmid">8358429</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0078">
<mixed-citation id="tjp7081-cit-0078" publication-type="journal">
<string-name>
<surname>Palmen</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>van Engeland</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hof</surname>
<given-names>PR</given-names>
</string-name> &amp; <string-name>
<surname>Schmitz</surname>
<given-names>C</given-names>
</string-name> (<year>2004</year>). <article-title>Neuropathological findings in autism</article-title>. <source/>Brain
<volume>127</volume>, <fpage>2572</fpage>–<lpage>2583</lpage>.<pub-id pub-id-type="pmid">15329353</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0079">
<mixed-citation id="tjp7081-cit-0079" publication-type="journal">
<string-name>
<surname>Parolin Schnekenberg</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Perkins</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Davies</surname>
<given-names>WI</given-names>
</string-name>, <string-name>
<surname>D'Adamo</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Pessia</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fawcett</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Sims</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Gillard</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Hudspith</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Skehel</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>O'Regan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jayawant</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jefferson</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Hughes</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lustenberger</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ragoussis</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jackson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tucker</surname>
<given-names>SJ</given-names>
</string-name> &amp; <string-name>
<surname>Németh</surname>
<given-names>AH</given-names>
</string-name> (<year>2015</year>). <article-title>De novo point mutations in patients diagnosed with ataxic cerebral palsy</article-title>. <source/>Brain
<volume>138</volume>, <fpage>1817</fpage>–<lpage>1832</lpage>.<pub-id pub-id-type="pmid">25981959</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0080">
<mixed-citation id="tjp7081-cit-0080" publication-type="journal">
<string-name>
<surname>Pereira</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Lambert</surname>
<given-names>HK</given-names>
</string-name>, <string-name>
<surname>Grossman</surname>
<given-names>YS</given-names>
</string-name>, <string-name>
<surname>Dumitriu</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Waldman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Jannetty</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Calakos</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Janssen</surname>
<given-names>WG</given-names>
</string-name>, <string-name>
<surname>McEwen</surname>
<given-names>BS</given-names>
</string-name> &amp; <string-name>
<surname>Morrison</surname>
<given-names>JH</given-names>
</string-name> (<year>2014</year>). <article-title>Glutamatergic regulation prevents hippocampal‐dependent age‐related cognitive decline through dendritic spine clustering</article-title>. <source/>Proc Natl Acad Sci USA
<volume>111</volume>, <fpage>18733</fpage>–<lpage>18738</lpage>.<pub-id pub-id-type="pmid">25512503</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0081">
<mixed-citation id="tjp7081-cit-0081" publication-type="journal">
<string-name>
<surname>Perkins</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Clarkson</surname>
<given-names>YL</given-names>
</string-name>, <string-name>
<surname>Sabatier</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Longhurst</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Millward</surname>
<given-names>CP</given-names>
</string-name>, <string-name>
<surname>Jack</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Toraiwa</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Watanabe</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rothstein</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Lyndon</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Wyllie</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Dutia</surname>
<given-names>MB</given-names>
</string-name> &amp; <string-name>
<surname>Jackson</surname>
<given-names>M</given-names>
</string-name> (<year>2010</year>). <article-title>Loss of β‐III spectrin leads to Purkinje cell dysfunction recapitulating the behavior and neuropathology of spinocerebellar ataxia type 5 in humans</article-title>. <source/>J Neurosci
<volume>30</volume>, <fpage>4857</fpage>–<lpage>4867</lpage>.<pub-id pub-id-type="pmid">20371805</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0082">
<mixed-citation id="tjp7081-cit-0082" publication-type="journal">
<string-name>
<surname>Peters</surname>
<given-names>LL</given-names>
</string-name>, <string-name>
<surname>Birkenmeier</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Bronson</surname>
<given-names>RT</given-names>
</string-name>, <string-name>
<surname>White</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Lux</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Otto</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Bennett</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Higgins</surname>
<given-names>A</given-names>
</string-name> &amp; <string-name>
<surname>Barker</surname>
<given-names>JE</given-names>
</string-name> (<year>1991</year>). <article-title>Purkinje cell degeneration associated with erythroid ankyrin deficiency in <italic>nb/nb</italic> mice</article-title>. <source/>J Cell Biol
<volume>114</volume>, <fpage>1235</fpage>–<lpage>1241</lpage>.</mixed-citation>
</ref>
<ref id="tjp7081-bib-0083">
<mixed-citation id="tjp7081-cit-0083" publication-type="journal">
<string-name>
<surname>Pielage</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fetter</surname>
<given-names>RD</given-names>
</string-name> &amp; <string-name>
<surname>Davis</surname>
<given-names>GW</given-names>
</string-name> (<year>2005</year>). <article-title>Presynaptic spectrin is essential for synapse stabilization</article-title>. <source/>Curr Biol
<volume>15</volume>, <fpage>918</fpage>–<lpage>928</lpage>.<pub-id pub-id-type="pmid">15916948</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0084">
<mixed-citation id="tjp7081-cit-0084" publication-type="journal">
<string-name>
<surname>Planes</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rooryck</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Vuillaume</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Besnard</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Bouron</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lacombe</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Arveiler</surname>
<given-names>B</given-names>
</string-name> &amp; <string-name>
<surname>Goizet</surname>
<given-names>C</given-names>
</string-name> (<year>2015</year>). <article-title>SCA27 is a cause of early‐onset ataxia and developmental delay</article-title>. <source/>Eur J Paediatr Neurol
<volume>19</volume>, <fpage>271</fpage>–<lpage>273</lpage>.<pub-id pub-id-type="pmid">25530029</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0085">
<mixed-citation id="tjp7081-cit-0085" publication-type="journal">
<string-name>
<surname>Potier</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Billard</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Rivière</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sinet</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Denis</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Champeil‐Potokar</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Grintal</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Jouvenceau</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kollen</surname>
<given-names>M</given-names>
</string-name> &amp; <string-name>
<surname>Dutar</surname>
<given-names>P</given-names>
</string-name> (<year>2010</year>). <article-title>Reduction in glutamate uptake is associated with extrasynaptic NMDA and metabotropic glutamate receptor activation at the hippocampal CA1 synapse of aged rats</article-title>. <source/>Aging Cell
<volume>9</volume>, <fpage>722</fpage>–<lpage>735</lpage>.<pub-id pub-id-type="pmid">20569241</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0086">
<mixed-citation id="tjp7081-cit-0086" publication-type="journal">
<string-name>
<surname>Pulst</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Nechiporuk</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Nechiporuk</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Gispert</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>XN</given-names>
</string-name>, <string-name>
<surname>Lopes‐Cendes</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Pearlman</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Starkman</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Orozco‐Diaz</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Lunkes</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>DeJong</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Rouleau</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Auburger</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Korenberg</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Figueroa</surname>
<given-names>C</given-names>
</string-name> &amp; <string-name>
<surname>Sahba</surname>
<given-names>S</given-names>
</string-name> (<year>1996</year>). <article-title>Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2</article-title>. <source/>Nat Genet
<volume>14</volume>, <fpage>269</fpage>–<lpage>276</lpage>.<pub-id pub-id-type="pmid">8896555</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0087">
<mixed-citation id="tjp7081-cit-0087" publication-type="book">
<string-name>
<surname>Rall</surname>
<given-names>W</given-names>
</string-name> (<year>1977</year>). <chapter-title>Core conductor theory and cable properties of neurons</chapter-title> In <source/>Handbook of Physiology, section I, <italic>The Nervous System</italic>, vol. I, ed <string-name>
<surname>Kandel</surname>
<given-names>ER</given-names>
</string-name>, pp. <fpage>39</fpage>–<lpage>97</lpage>. American Physiological Society, Bethesda.</mixed-citation>
</ref>
<ref id="tjp7081-bib-0088">
<mixed-citation id="tjp7081-cit-0088" publication-type="journal">
<string-name>
<surname>Raman</surname>
<given-names>IM</given-names>
</string-name> &amp; <string-name>
<surname>Bean</surname>
<given-names>BP</given-names>
</string-name> (<year>1997</year>). <article-title>Resurgent sodium current and action potential formation in dissociated cerebellar Purkinje neurons</article-title>. <source/>J Neurosci
<volume>17</volume>, <fpage>4517</fpage>–<lpage>4526</lpage>.<pub-id pub-id-type="pmid">9169512</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0089">
<mixed-citation id="tjp7081-cit-0089" publication-type="journal">
<string-name>
<surname>Raman</surname>
<given-names>IM</given-names>
</string-name>, <string-name>
<surname>Sprunger</surname>
<given-names>LK</given-names>
</string-name>, <string-name>
<surname>Meisler</surname>
<given-names>MH</given-names>
</string-name> &amp; <string-name>
<surname>Bean</surname>
<given-names>BP</given-names>
</string-name> (<year>1997</year>). <article-title>Altered subthreshold sodium currents and disrupted firing patterns in Purkinje neurons of Scn8a mutant mice</article-title>. <source/>Neuron
<volume>19</volume>, <fpage>881</fpage>–<lpage>891</lpage>.<pub-id pub-id-type="pmid">9354334</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0090">
<mixed-citation id="tjp7081-cit-0090" publication-type="journal">
<string-name>
<surname>Ranum</surname>
<given-names>LP</given-names>
</string-name>, <string-name>
<surname>Schut</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Lundgren</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Orr</surname>
<given-names>HT</given-names>
</string-name> &amp; <string-name>
<surname>Livingston</surname>
<given-names>DM</given-names>
</string-name> (<year>1994</year>). <article-title>Spinocerebellar ataxia type 5 in a family descended from the grandparents of President Lincoln maps to chromosome 11</article-title>. <source/>Nat Genet
<volume>8</volume>, <fpage>280</fpage>–<lpage>284</lpage>.<pub-id pub-id-type="pmid">7874171</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0091">
<mixed-citation id="tjp7081-cit-0091" publication-type="journal">
<string-name>
<surname>Ruano</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Melo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Silva</surname>
<given-names>MC</given-names>
</string-name> &amp; <string-name>
<surname>Coutinho</surname>
<given-names>P</given-names>
</string-name> (<year>2014</year>). <article-title>The global epidemiology of hereditary ataxia and spastic paraplegia: A systematic review of prevalence studies</article-title>. <source/>Neuroepidemiology
<volume>42</volume>, <fpage>174</fpage>–<lpage>183</lpage>.<pub-id pub-id-type="pmid">24603320</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0092">
<mixed-citation id="tjp7081-cit-0092" publication-type="journal">
<string-name>
<surname>Sanpei</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Takano</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Igarashi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Oyake</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sasaki</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wakisaka</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tashiro</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ishida</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ikeuchi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Koide</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Saito</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hanyu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Takiyama</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Nishizawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Shimizu</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Nomura</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Segawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Iwabuchi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Eguchi</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>H</given-names>
</string-name> &amp; <string-name>
<surname>Tsuji</surname>
<given-names>S</given-names>
</string-name> (<year>1996</year>). <article-title>Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT</article-title>. <source/>Nat Genet
<volume>14</volume>, <fpage>277</fpage>–<lpage>284</lpage>.<pub-id pub-id-type="pmid">8896556</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0093">
<mixed-citation id="tjp7081-cit-0093" publication-type="journal">
<string-name>
<surname>Sato</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Amino</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kobayashi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Asakawa</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ishiguro</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tsunemi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Matsuura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Flanigan</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Iwasaki</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ishino</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Saito</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Murayama</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yoshida</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hashizume</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tsuji</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shimizu</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Toda</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ishikawa</surname>
<given-names>K</given-names>
</string-name> &amp; <string-name>
<surname>Mizusawa</surname>
<given-names>H</given-names>
</string-name> (<year>2009</year>). <article-title>Spinocerebellar ataxia type 31 is associated with “inserted” penta‐nucleotide repeats containing (TGGAA)<sub>n</sub>
</article-title>. <source/>Am J Hum Genet
<volume>85</volume>, <fpage>544</fpage>–<lpage>557</lpage>.<pub-id pub-id-type="pmid">19878914</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0094">
<mixed-citation id="tjp7081-cit-0094" publication-type="journal">
<string-name>
<surname>Schmahmann</surname>
<given-names>JD</given-names>
</string-name> &amp; <string-name>
<surname>Sherman</surname>
<given-names>JC</given-names>
</string-name> (<year>1998</year>). <article-title>The cerebellar cognitive affective syndrome</article-title>. <source/>Brain
<volume>121</volume>, <fpage>561</fpage>–<lpage>579</lpage>.<pub-id pub-id-type="pmid">9577385</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0095">
<mixed-citation id="tjp7081-cit-0095" publication-type="journal">
<string-name>
<surname>Seki</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Shimahara</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Abe</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Amano</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Adachi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kashiwagi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Saito</surname>
<given-names>N</given-names>
</string-name> &amp; <string-name>
<surname>Sakai</surname>
<given-names>N</given-names>
</string-name> (<year>2009</year>). <article-title>Mutant γPKC found in spinocerebellar ataxia type 14 induces aggregate‐independent maldevelopment of dendrites in primary cultured Purkinje cells</article-title>. <source/>Neurobiol Dis
<volume>33</volume>, <fpage>260</fpage>–<lpage>273</lpage>.<pub-id pub-id-type="pmid">19041943</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0096">
<mixed-citation id="tjp7081-cit-0096" publication-type="journal">
<string-name>
<surname>Serra</surname>
<given-names>HG</given-names>
</string-name>, <string-name>
<surname>Byam</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Lande</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Tousey</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</string-name> &amp; <string-name>
<surname>Orr</surname>
<given-names>HT</given-names>
</string-name> (<year>2004</year>). <article-title>Gene profiling links SCA1 pathophysiology to glutamate signalling in Purkinje cells of transgenic mice</article-title>. <source/>Hum Mol Genet
<volume>13</volume>, <fpage>2535</fpage>–<lpage>2543</lpage>.<pub-id pub-id-type="pmid">15317756</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0097">
<mixed-citation id="tjp7081-cit-0097" publication-type="journal">
<string-name>
<surname>Shakkottai</surname>
<given-names>VG</given-names>
</string-name>, <string-name>
<surname>Chou</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Oddo</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sailer</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Knaus</surname>
<given-names>HG</given-names>
</string-name>, <string-name>
<surname>Gutman</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Barish</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>LaFerla</surname>
<given-names>FM</given-names>
</string-name> &amp; <string-name>
<surname>Chandy</surname>
<given-names>KG</given-names>
</string-name> (<year>2004</year>). <article-title>Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia</article-title>. <source/>J Clin Invest
<volume>113</volume>, <fpage>582</fpage>–<lpage>590</lpage>.<pub-id pub-id-type="pmid">14966567</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0098">
<mixed-citation id="tjp7081-cit-0098" publication-type="journal">
<string-name>
<surname>Shakkottai</surname>
<given-names>VG</given-names>
</string-name>, <string-name>
<surname>do Carmo Costa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Dell'Orco</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Sankaranarayanan</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wulff</surname>
<given-names>H</given-names>
</string-name> &amp; <string-name>
<surname>Paulson</surname>
<given-names>HL</given-names>
</string-name> (<year>2011</year>). <article-title>Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3</article-title>. <source/>J Neurosci
<volume>31</volume>, <fpage>13002</fpage>–<lpage>13014</lpage>.<pub-id pub-id-type="pmid">21900579</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0099">
<mixed-citation id="tjp7081-cit-0099" publication-type="journal">
<string-name>
<surname>Shakkottai</surname>
<given-names>VG</given-names>
</string-name>, <string-name>
<surname>Xiao</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nerbonne</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Ornitz</surname>
<given-names>DM</given-names>
</string-name> &amp; <string-name>
<surname>Yamada</surname>
<given-names>KA</given-names>
</string-name> (<year>2009</year>). <article-title>FGF14 regulates the intrinsic excitability of cerebellar Purkinje neurons</article-title>. <source/>Neurobiol Dis
<volume>33</volume>, <fpage>81</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="pmid">18930825</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0100">
<mixed-citation id="tjp7081-cit-0100" publication-type="journal">
<string-name>
<surname>Sjöbeck</surname>
<given-names>M</given-names>
</string-name> &amp; <string-name>
<surname>Englund</surname>
<given-names>E</given-names>
</string-name> (<year>2001</year>). <article-title>Alzheimer's disease and the cerebellum: a morphologic study on neuronal and glial changes</article-title>. <source/>Dement Geriatr Cogn Disord
<volume>12</volume>, <fpage>211</fpage>–<lpage>218</lpage>.<pub-id pub-id-type="pmid">11244215</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0101">
<mixed-citation id="tjp7081-cit-0101" publication-type="journal">
<string-name>
<surname>Stankewich</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Gwynn</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Ardito</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ji</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Robledo</surname>
<given-names>RF</given-names>
</string-name>, <string-name>
<surname>Lux</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Peters</surname>
<given-names>LL</given-names>
</string-name> &amp; <string-name>
<surname>Morrow</surname>
<given-names>JS</given-names>
</string-name> (<year>2010</year>). <article-title>Targeted deletion of βIII spectrin impairs synaptogenesis and generates ataxic and seizure phenotypes</article-title>. <source/>Proc Natl Acad Sci USA
<volume>107</volume>, <fpage>6022</fpage>–<lpage>6027</lpage>.<pub-id pub-id-type="pmid">20231455</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0102">
<mixed-citation id="tjp7081-cit-0102" publication-type="journal">
<string-name>
<surname>Stevanin</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Herman</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Brice</surname>
<given-names>A</given-names>
</string-name> &amp; <string-name>
<surname>Dürr</surname>
<given-names>A</given-names>
</string-name> (<year>1999</year>). <article-title>Clinical and MRI findings in spinocerebellar ataxia type 5</article-title>. <source/>Neurology
<volume>53</volume>, <fpage>1355</fpage>–<lpage>1357</lpage>.<pub-id pub-id-type="pmid">10522902</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0103">
<mixed-citation id="tjp7081-cit-0103" publication-type="journal">
<string-name>
<surname>Stoodley</surname>
<given-names>CJ</given-names>
</string-name> &amp; <string-name>
<surname>Stein</surname>
<given-names>JF</given-names>
</string-name> (<year>2011</year>). <article-title>The cerebellum and dyslexia</article-title>. <source/>Cortex
<volume>47</volume>, <fpage>101</fpage>–<lpage>116</lpage>.<pub-id pub-id-type="pmid">20060110</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0104">
<mixed-citation id="tjp7081-cit-0104" publication-type="journal">
<string-name>
<surname>Tsoi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>ZS</given-names>
</string-name>, <string-name>
<surname>Ng</surname>
<given-names>NK</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>AY</given-names>
</string-name>, <string-name>
<surname>Yuen</surname>
<given-names>LY</given-names>
</string-name>, <string-name>
<surname>Abrigo</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Tsang</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Tsui</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Tong</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Lo</surname>
<given-names>IF</given-names>
</string-name>, <string-name>
<surname>Lam</surname>
<given-names>ST</given-names>
</string-name>, <string-name>
<surname>Mok</surname>
<given-names>VC</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>LK</given-names>
</string-name>, <string-name>
<surname>Ngo</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Lau</surname>
<given-names>KF</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>TF</given-names>
</string-name> &amp; <string-name>
<surname>Chan</surname>
<given-names>HY</given-names>
</string-name> (<year>2014</year>). <article-title>A novel missense mutation in CCDC88C activates the JNK pathway and causes a dominant form of spinocerebellar ataxia</article-title>. <source/>J Med Genet
<volume>51</volume>, <fpage>590</fpage>–<lpage>595</lpage>.<pub-id pub-id-type="pmid">25062847</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0105">
<mixed-citation id="tjp7081-cit-0105" publication-type="journal">
<string-name>
<surname>van de Leemput</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chandran</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Knight</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Holtzclaw</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Scholz</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cookson</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Houlden</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Gwinn‐Hardy</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Fung</surname>
<given-names>HC</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Hernandez</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Simon‐Sanchez</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wood</surname>
<given-names>NW</given-names>
</string-name>, <string-name>
<surname>Giunti</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Rafferty</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Storey</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Gardner</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Forrest</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Fisher</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Russell</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>H</given-names>
</string-name> &amp; <string-name>
<surname>Singleton</surname>
<given-names>AB</given-names>
</string-name> (<year>2007</year>). <article-title>Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans</article-title>. <source/>PLoS Genet
<volume>3</volume>, <fpage>e108</fpage>
<pub-id pub-id-type="pmid">17590087</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0106">
<mixed-citation id="tjp7081-cit-0106" publication-type="journal">
<string-name>
<surname>van Swieten</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Brusse</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>de Graaf</surname>
<given-names>BM</given-names>
</string-name>, <string-name>
<surname>Krieger</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>van de Graaf</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>de Koning</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Maat‐Kievit</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Leegwater</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Dooijes</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Oostra</surname>
<given-names>BA</given-names>
</string-name> &amp; <string-name>
<surname>Heutink</surname>
<given-names>P</given-names>
</string-name> (<year>2003</year>). <article-title>A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia</article-title>. <source/>Am J Hum Genet
<volume>72</volume>, <fpage>191</fpage>–<lpage>199</lpage>.<pub-id pub-id-type="pmid">12489043</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0107">
<mixed-citation id="tjp7081-cit-0107" publication-type="journal">
<string-name>
<surname>Wadiche</surname>
<given-names>JI</given-names>
</string-name> &amp; <string-name>
<surname>Jahr</surname>
<given-names>CE</given-names>
</string-name> (<year>2005</year>). <article-title>Patterned expression of Purkinje cell glutamate transporters controls synaptic plasticity</article-title>. <source/>Nat Neurosci
<volume>8</volume>, <fpage>1329</fpage>–<lpage>1334</lpage>.<pub-id pub-id-type="pmid">16136036</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0108">
<mixed-citation id="tjp7081-cit-0108" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Xia</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>ZM</given-names>
</string-name>, <string-name>
<surname>Weng</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>YR</given-names>
</string-name>, <string-name>
<surname>Lei</surname>
<given-names>LF</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Du</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>YF</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>RQ</given-names>
</string-name> &amp; <string-name>
<surname>Tang</surname>
<given-names>BS</given-names>
</string-name> (<year>2010</year>). <article-title>TGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing</article-title>. <source/>Brain
<volume>133</volume>, <fpage>3510</fpage>–<lpage>3518</lpage>.<pub-id pub-id-type="pmid">21106500</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0109">
<mixed-citation id="tjp7081-cit-0109" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Bardgett</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wozniak</surname>
<given-names>DF</given-names>
</string-name>, <string-name>
<surname>Lou</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>McNeil</surname>
<given-names>BD</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Nardi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Reid</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Yamada</surname>
<given-names>K</given-names>
</string-name> &amp; <string-name>
<surname>Ornitz</surname>
<given-names>DM</given-names>
</string-name> (<year>2002</year>). <article-title>Ataxia and paroxysmal dyskinesia in mice lacking axonally transported FGF14</article-title>. <source/>Neuron
<volume>35</volume>, <fpage>25</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="pmid">12123606</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0110">
<mixed-citation id="tjp7081-cit-0110" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Koh</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Miwa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yamashiro</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Shindo</surname>
<given-names>K</given-names>
</string-name> &amp; <string-name>
<surname>Takiyama</surname>
<given-names>Y</given-names>
</string-name> (<year>2014</year>). <article-title>A Japanese SCA5 family with a novel three‐nucleotide in‐frame deletion mutation in the SPTBN2 gene: a clinical and genetic study</article-title>. <source/>J Hum Genet
<volume>59</volume>, <fpage>569</fpage>–<lpage>573</lpage>.<pub-id pub-id-type="pmid">25142508</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0111">
<mixed-citation id="tjp7081-cit-0111" publication-type="journal">
<string-name>
<surname>Waters</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Minassian</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Stevanin</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Figueroa</surname>
<given-names>KP</given-names>
</string-name>, <string-name>
<surname>Bannister</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Nolte</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Mock</surname>
<given-names>AF</given-names>
</string-name>, <string-name>
<surname>Evidente</surname>
<given-names>VG</given-names>
</string-name>, <string-name>
<surname>Fee</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Müller</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Dürr</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Brice</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Papazian</surname>
<given-names>DM</given-names>
</string-name> &amp; <string-name>
<surname>Pulst</surname>
<given-names>SM</given-names>
</string-name> (<year>2006</year>). <article-title>Mutations in voltage‐gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes</article-title>. <source/>Nat Genet
<volume>38</volume>, <fpage>447</fpage>–<lpage>451</lpage>.<pub-id pub-id-type="pmid">16501573</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0112">
<mixed-citation id="tjp7081-cit-0112" publication-type="journal">
<string-name>
<surname>Whitney</surname>
<given-names>ER</given-names>
</string-name>, <string-name>
<surname>Kemper</surname>
<given-names>TL</given-names>
</string-name>, <string-name>
<surname>Bauman</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Rosene</surname>
<given-names>DL</given-names>
</string-name> &amp; <string-name>
<surname>Blatt</surname>
<given-names>GJ</given-names>
</string-name> (<year>2008</year>). <article-title>Cerebellar Purkinje cells are reduced in a subpopulation of autistic brains: a stereological experiment using calbindin‐D28k</article-title>. <source/>Cerebellum
<volume>7</volume>, <fpage>406</fpage>–<lpage>416</lpage>.<pub-id pub-id-type="pmid">18587625</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0113">
<mixed-citation id="tjp7081-cit-0113" publication-type="journal">
<string-name>
<surname>Yamada</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Watanabe</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Shibata</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wada</surname>
<given-names>K</given-names>
</string-name> &amp; <string-name>
<surname>Inoue</surname>
<given-names>Y</given-names>
</string-name> (<year>1996</year>). <article-title>EAAT4 is a post‐synaptic glutamate transporter at Purkinje cell synapses</article-title>. <source/>Neuroreport
<volume>7</volume>, <fpage>2013</fpage>–<lpage>2017</lpage>.<pub-id pub-id-type="pmid">8905715</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0114">
<mixed-citation id="tjp7081-cit-0114" publication-type="journal">
<string-name>
<surname>Yan</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Pablo</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>C</given-names>
</string-name> &amp; <string-name>
<surname>Pitt</surname>
<given-names>GS</given-names>
</string-name> (<year>2014</year>). <article-title>FGF14 modulates resurgent sodium current in mouse cerebellar Purkinje neurons</article-title>. <source/>Elife
<volume>3</volume>, <fpage>e04193</fpage>.<pub-id pub-id-type="pmid">25269146</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0115">
<mixed-citation id="tjp7081-cit-0115" publication-type="journal">
<string-name>
<surname>Zhuchenko</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Bailey</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Bonnen</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ashizawa</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Stockton</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Amos</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Dobyns</surname>
<given-names>WB</given-names>
</string-name>, <string-name>
<surname>Subramony</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</string-name> &amp; <string-name>
<surname>Lee</surname>
<given-names>CC</given-names>
</string-name> (<year>1997</year>). <article-title>Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α<sub>1A</sub>‐voltage‐dependent calcium channel</article-title>. <source/>Nat Genet
<volume>15</volume>, <fpage>62</fpage>–<lpage>69</lpage>.<pub-id pub-id-type="pmid">8988170</pub-id></mixed-citation>
</ref>
<ref id="tjp7081-bib-0116">
<mixed-citation id="tjp7081-cit-0116" publication-type="journal">
<string-name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</string-name> (<year>1991</year>). <article-title>The spinocerebellar degenerations</article-title>. <source/>Curr Neurol
<volume>11</volume>, <fpage>121</fpage>–<lpage>144</lpage>.</mixed-citation>
</ref>
<ref id="tjp7081-bib-0117">
<mixed-citation id="tjp7081-cit-0117" publication-type="journal">
<string-name>
<surname>Zühlke</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Bernard</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Dalski</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lorenz</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Mitulla</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Gillessen‐Kaesbach</surname>
<given-names>G</given-names>
</string-name> &amp; <string-name>
<surname>Bürk</surname>
<given-names>K</given-names>
</string-name> (<year>2007</year>). <article-title>Screening of the SPTBN2 (SCA5) gene in German SCA patients</article-title>. <source/>J Neurol
<volume>254</volume>, <fpage>1649</fpage>–<lpage>1652</lpage>.<pub-id pub-id-type="pmid">17940722</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>